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Chapter 1
Introduction
1.1 Photosensitization by drugs
1.1.1 General photophysical concepts
Electronic states and excitation of organic molecules
Organic photochemistry is a science concerned with the processes that result
from interaction of light with organic molecules [1]. The functional group respon-
sible for light absorption is denominated chromophore, thus it represents the sub-
structure of an organic molecule that is primarily responsible for its photochemical
activity.
From a fundamental point of view, photochemistry is a matter of molecu-
lar orbitals, which originate from the overlap of atomic s and p orbitals. They are
classified into three main classes, bonding (σ or pi), antibonding (σ∗ or pi∗) and non-
bonding orbitals(n). Most organic molecules are closed-shell molecules, in which
the highest occupied molecular orbitals (HOMOs) are bonding σ, pi or nonbonding
n orbitals. Upon excitation, an electron of the chromophore may be promoted into
the lowest unoccupied molecular orbital (LUMO), which is usually an antibonding
σ∗ or pi∗ orbital. Thus, most frequent excitations of organic molecule chromophores
are:
• pi → pi∗, exhibited by alkenes, alkynes and aromatic molecules
• n → pi∗, exhibited by compounds containing carbonyl, thiocarbonyl, nitro,
azo and imin groups
• n → σ∗, exhibited by amines, alcohols and haloalkanes
Each electron in a molecule carries a spin angular momentum with a spin
quantum number s=1/2, it can take one of two orientations:
• Spin up: ↑ or α
1
CHAPTER 1. INTRODUCTION
• Spin down: ↓ or β
The total spin angular momentum of a molecule is represented by the total
spin quantum number S, which is the vector sum of electron spin quantum number.
If spins are opposite, the sum is 0, if they are parallel is it 1. The spin multiplicity
is given by 2S+1.
In the ground electronic state of most organic molecules, all electrons are spin-
paired, thus it means that S=0 and spin multiplicity is 1. This condition is called
singlet state and is abbreviated as S0.
After the light absorption, an electron is promoted to an antibonding orbital:
• if electrons are still paired, the total spin quantum number is zero, so this
state corresponds still to a singlet state abbreviated as S1.
• If electrons are aligned in parallel S=1 and the spin multiplicity is 3. This
condition is called triplet state and is abbreviated as T1.
The energy of triplet state is generally lower than that of singlet state. The
reason is the fact that the repulsion between two electrons occupying different or-
bitals is minimized if their spins are opposed.
For most organic molecules excited from their ground state, preservation of the
spin multiplicity favors singlet-singlet transitions and forbids singlet-triplet transi-
tion. In spite of this, coupling between electronic and nuclear motion enables some
symmetry-forbidden transitions to become weakly allowed.
Deactivation of excited molecules
The electronically excited molecules are energetically unstable with regard to
the ground state. Consequently molecules could rearrange or fragment (photochem-
istry) or loose their excitation energy to return to the ground state (photophysics).
Three deactivation pathways are possible (Figure 1.1):
• Radiative processes: emission of an electromagnetic radiation (fluorescence
and phosphorescence).
• Nonradiative processes: nonradiative transition to another electronic state.
• Quenching processes: deactivation by collision with another molecule.
In the first case, the emitted light has a longer wavelength, thus a lower en-
ergy, than the absorbed radiation. Fluorescence is the emission that occurs from
an excited state with the same spin multiplicity than the ground state (usually
from S1 to S0). As absorption, fluorescence is strongly allowed, for that reason it
takes place on fast timescale from picoseconds to microseconds. Phosphorescence
emission is originated during the deactivation of an excited state of spin multiplic-
ity different from that of the ground state (for example T1→ S0). Its timescale is
2
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Figure 1.1: The Jablonski diagram, where hν: absortion, -hν’: fluorescence, -hν”: phosphores-
cence, IC: internal conversion, ISC: intersystem crossing.
of milliseconds to seconds.
Nonradiative transition is defined by an intramolecular process that involves
a conversion, at a constant energy, from one state to another one. The latter is
produced with some excess of vibrational energy and relaxes rapidly by releasing
heat. Radiationless transitions can correspond to:
• Internal Conversion (IC) when it involves electronic state of the same spin
multiplicity (for example S2→ S1).
• Intersystem Crossing (ISC) when it involves electronic states of different spin
multiplicity (for example S1→ T1).
In the quenching process, the de-excitation of the excited molecule is performed
by another molecule called quencher. This bimolecular process is followed by the
decrease of the excited molecule concentration. In the next section, details of two
quenching processes are exposed.
Electronic energy transfer and photoinducted electron transfer
Electronic energy transfer (ET) is defined by the IUPAC as the photophysical
process in which an excited state of one molecular entity (the donor, M) is deacti-
vated to a lower-lying state by transferring energy to a second molecular entity (the
acceptor, Q) which is thereby raised to a higher energy state. Thus, the reaction
may be written as follows:
M∗ +Q→M +Q∗ (1.1)
where, the initially excited M* transfers energy to a suitable acceptor molecule
(Q) with energy levels near or below the energy level of the donor. This results in
the simultaneous quenching of M* and excitation of Q. The species Q*, indirectly
excited, can then undergo various photochemical and photophysical processes, such
3
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processes are called photosensitized reactions.
Depending on spin multiplicity of M and Q various energy transfer processes
can occur (singlet-singlet, triplet-triplet). Here, the attention has been centered in
the process studied in the experimental work of this thesis: the triplet-triplet energy
transfer (TTET), M∗T1+QS0 → MS0+Q∗T1. This processes is a quite common
method to produce triplet state when a molecule has a low ISC quantum yield.
In this context, the Q triplet state could not be produced in high yield by direct
excitation, and thus M is used as a photosensitizer. The efficiency of TTET depends
on the energy gap between the triplet excited state energies of M and Q. Indeed,
the bimolecular rate constant of this process (kTT ) can be determined by using
the Sandros equation (Eq.1.2), which takes into account the triplet energies of M*
(EM∗T ) and Q (E
Q∗
T ), and the diffusion rate constant of the medium (kdiff ) [2].
kTT = kdiff/(1 + exp(−(EM∗T − EQ∗T )/RT )) (1.2)
Formation of singlet oxygen is also a photosensitized process, which generally
occurs by quenching of triplet excited state of the donor by molecular oxygen O2:
M*T1+QT0 → MS0+Q*S1. It is noteworthy that the ground state of molecular
oxygen is a triplet state, which after sensitization is activated to its singlet state,
giving rise to the so-called singlet oxygen. Indeed, molecular oxygen has the highest
electrons unpaired (with the same spin) in the degenerated pi∗x and pi∗y orbitals,
so into ground state molecular oxygen is a triplet state (3Σu). Upon excitation, the
electrons become paired, so the excited oxygen is a singlet state 1∆g or 1O2. As
explained above, this process is spin forbidden, so 1O2 is obtained through energy
transfer generally from a triplet excited state, although some cases of singlet excited
state sensitization also exist.
Electronically excited state molecules are more potent electron acceptors or
donors compared to the ground state. Photoinducted electron transfer (PET) is
an excited state electron transfer process by which an electron is transferred from
the donor to the acceptor. This reaction is favored in polar solvent, which is able
to solvate better charged species allowing a better charge separation. Depending
on the redox properties of both species, two processes are possible:
• M*+Q→ +•M+Q−• : reductive quenching
• M*+Q→ −•M+Q+• : oxidative quenching
Taking the oxidative quenching as example, the thermodynamics of the reac-
tion can be determined by the Rehm-Weller equation [3]:
∆G0 = E0(Q/Q+•)− E0(M−•/M∗) (1.3)
Where ∆G0 is the free energy changes of the photoreaction, E0(Q/Q+•) the
oxidation potential of Q in its ground state and E0(M−•/M∗) the reduction po-
tential of M in its excited state.
As the latter can be expressed as E0(M−•/M∗) = E0(M−•/M)-∆E0−0, equa-
tion 1.3 can be converted into:
4
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∆G0 = E(Q/Q+•)− E(M−•/M)−∆E0−0 (1.4)
1.1.2 Type I and Type II oxidation
Photosensitized reactions are classified into two processes called Type I and
Type II. It has been generally recognized that the triplet state of the photosensi-
tizer is generally the key species in such processes (Figure 1.2). In this context,
it is considered as the biologically active intermediate because of its central role
in biomolecule sensitization. In the Type I reaction, the excited photosensitizer
reacts directly with the substrate, by electron transfer or hydrogen abstraction,
to produce radical ions or neutral radicals. Although electron transfer can pro-
ceed in either direction, usually the biological substrate donates an electron to the
sensitizer, resulting in a substrate radical cation (Sub•+), and a sensitizer radical
anion (Sen•−). At this stage, Sen•−can transfer an electron to molecular oxygen
to produce the superoxide radical anion (O2•−), and regenerate the original sen-
sitizer. In the Type II mechanism, the excited sensitizer transfers its energy to
molecular oxygen giving rise to the reactive singlet oxygen, and regenerating the
ground-state sensitizer. Singlet oxygen then reacts with the substrate to generate
oxidized products. Generally the photosensitizer is not consumed during this type
of reaction, unless it reacts with 1O2.
Figure 1.2: Mechanistic pathways involved in the photosensitization processes of biomolecules.
Figure redrawn from reference [4]
Lipids, proteins and DNA are substrates of Type I sensitization [5–7]. It should
be underlined that the amino acids or DNA nucleobases with the lowest oxidation
potential are the main target during the electron transfer process. These substrates
are guanine for DNA (Figure 1.3) and tyrosine or tryptophan for proteins.
Concerning the Type II processes with lipids, addition of the highly elec-
trophilic singlet oxygen to the double bonds of unsaturated fatty acids generates
hydroperoxides (Figure 1.4)[6]. In the case of proteins, tryptophan and histidine
are the most reactive amino acids and their oxidation also results in the forma-
tion of hydroperoxides as shown in Figure 1.5 [7]. The production of modified
proteins as a result of 1O2-mediated photooxidation can promote a wide range of
5
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Figure 1.3: One electron oxidation of guanine nucleobase. R is the DNA chain
biophysical and biochemical changes in both the properties and functions of pro-
teins: increased or decreased susceptibility to proteolytic enzymes, modifications
in mechanical properties and changes in binding of co-factors and metal ions. This
may have major effects on cellular function, the inhibition of key cellular enzymes
and the potential induction of DNA damage, suggesting that these species may be
key intermediates in cellular dysfunction and disease progression.
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Unless the DNA four bases are in principle susceptible to be oxidized by sin-
glet oxygen, reaction only occurs with 2’-deoxyguanosine giving rise to 8-oxo-7,8-
dihydro-2’-deoxyguanosine (8-oxodG, Figure 1.6). This compound reacts even eas-
ier with 1O2 leading to further oxidized photoproducts. Formation of these dam-
ages gives rise to abasic sites in DNA together with single and double DNA strand
breaks and can ultimately result in G-T transversions.[5]
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Figure 1.6: Main oxidation product produced by the reaction of 1O2 with the guanine moiety.
1.2 Principles of drug phototoxicity
Ultraviolet solar radiation reaching the earth surface corresponds predomi-
nantly to UVA radiation as the portion of UVB represents less than 5%. While
UVC (100 - 290 nm) is totally absorbed by the atmosphere, UVB (290-320 nm)
cannot penetrate beyond the superficial skin layers but is biologically active (vi-
tamin D photosynthesis, local and systemic immunosuppression). Concerning the
UVA (320-400 nm), it is not significantly filtered by the atmosphere and can pen-
etrate into the deeper layers of the skin; but, however, it is only scarcely absorbed
directly by the biomacromolecules. In spite of this, UVA is able to activate chem-
icals (ie. photosensitizers) extending the range of biologically relevant UV light
and triggering indirectly biological damage. Sunlight exposure could lead to severe
skin reactions: erythema, pruritus, urticaria etc. . ., but also to skin cancers like
squamous and basal cell carcinoma or even melanoma. In this context, it has been
evidenced that melanoma skin cancer is directly associated with sunlight exposure.
In Europe, its incidence has largely increased since 1975. It is the 5th most com-
monly diagnosed cancer with 82100 cases in 2012 and a mortality of 15700 cases [8].
Furthermore, an important issue of healthcare relies on the photosensitizing effect
of xenobiotics since modern lifestyle often associates sunlight exposure with the
presence of chemical substances in the skin (daily life chemicals like perfumes, sun-
screen components and therapeutic agents). Photosensitization is identified by the
development of abnormal cutaneous reactions triggered by sunlight doses regarded
as harmless, most often in the UVA range. Thus, a photosensitizing compound,
generally not toxic by itself, becomes reactive under irradiation [9]. Photosensi-
tivity induced by xenobiotics is divided into two phenomena: phototoxicity and
photoallergy. Phototoxicity can be elicited by a wide range of agents (but also
by their metabolites or photoproducts). The reaction is essentially immediate and
resembles an exaggerated sunburn. Phototoxic reactions are much more preva-
lent than photoallergic ones. They depend on the light dose received and on the
photosensitizer concentration in the skin. Moreover, they exhibit a maximum in-
7
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tensity early after UV exposure, followed by a decrescendo evolution within 24-72
h. Eruptions occur only on exposed skin areas and the lesions are characterized
by erythema, infiltration, edema, or blisters, followed by desquamation and hy-
perpigmentation. It has also been suggested that repeated phototoxic reactions
have the potential to increase the already high risk of skin cancer from sunburn
[4]. By contrast, photoallergy is uncommon and immunologically mediated and
requires previous exposure to the photosensitizing agent and an induction period.
Clinically, it is very similar to contact allergic reactions, with a delayed onset and
a crescendo reaction pattern. Photoallergic contact dermatitis may generally affect
well defined areas exposed to sunlight, but it may extend to other parts of the body,
sometimes distant from the initially affected area. The corresponding skin lesions
are erythema, infiltration, papulovesicles, erosions, or bullae. The molecular mech-
anism completely differs from that of phototoxicity; the irradiated drug (metabolite
or photoproduct) plays the role of a photohapten, which can covalently bind to a
carrier protein (photobinding), giving rise to a photoantigen able to trigger the
immunological process.
A mechanistically based approach taking into account the sensitizer photo-
physical and photochemical properties has to be considered for a deeper under-
standing of the molecular processes involved in the photosensitivity side effects.
Indeed, the primary characteristic for a compound to be considered a potential
photosensitizing agent is the absorption in the UVA-UVB and visible range (λ>290
nm). Upon excitation, the molecule reaches a singlet excited state, which can cross
to the triplet excited state. This latter has been recognized as the key intermedi-
ate responsible for most of the biomolecule damage formation through Type I/II
mechanisms or triplet-triplet energy transfer.
1.2.1 Phototoxicity of statin drugs
As explained above, photosensitizing effects of xenobiotics are of increasing
concern in dermatology. This section is focused on statin drugs, which are the most
prescribed hypolipemiants in Europe and in the USA (with annual sales in excess
of $22 billion). These lipid-lowering agents act in an early and rate-limiting step of
cholesterol biosynthesis by competitive inhibition of 3-hydroxy-3-methylglutaryl-
coenzyme A (HMG-CoA) reductase, an enzyme that catalyzes the conversion of
HMG-CoA to mevalonate by NADPH as reductor (Figure 1.7). Specifically, the
bulky and hydrophobic moiety of statins fills the HMG-binding pocket and part of
the binding surface of coenzyme A (CoA). This interaction prevents the access of
HMG-CoA to HMG reductase [10].
Interestingly, several clinical cases of cutaneous reactions have been reported
and associated with photosensivity disorders [11–17]. As example, it can be men-
tioned: eruptions, dermatitis, porphyria cutanea, chronic actinic dermatitis, cuta-
neous lupus erythematosus.
Indeed, two different mechanisms have been suggested to explain the molec-
ular basis of the statin sensitization process. The first one does not require light
8
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Figure 1.7: Step of the biosynthesis of isoprenoids and sterols inhibited by statins: the four-
electron reductive deacylation of HMG-CoA to coenzyme A and mevalonate.
absorption by the drug and deals with drug alteration of the cell metabolism, which
finally triggers the photosensitivity. This scenario has been proposed to account
for the photosensitivity induced by lovastatin (Figure 1.8), which in spite of its lack
of absorbance above 280 nm has been shown to be responsible for an enhancement
of keratinocyte cellular damage under UVA-irradiation (Table 1.1)[18, 19]. In-
deed, it has been advanced that this HMG-CoA inhibitor produces an alteration of
cholesterol cell content, which results in a higher sensitivity under UVA-irradiation.
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Figure 1.8: Structures of Lovastatin, Fluvastatin and Fluvastatin photoproduct
The second mechanism is based on drug photolability and puts foward that,
upon light absorption, the phototoxic effect of statins is not mediated by the parent
drug but by one of its photoproducts. An interesting case relies on the phototoxic
potential of fluvastatin (Figure 1.8), which has been established by in vitro studies
of UVA-irradiated human keratinocytes and 3T3 fibroblasts. One of fluvastatin
photoproducts (Figure 1.8), a benzocarbazole-like compound, has been revealed to
9
CHAPTER 1. INTRODUCTION
Cell viability (%)
No irradiated Irradiated
Control 100 79
Lovastatin 97 22
Lovastatin + cholesterol 97 77
Lovastatin + LDL protein 96 72
Table 1.1: Effect of Lovastatin (alone or with protectors) on the 24h UVA-induced photocytotox-
icity in cultured human cell. Table modified from ref[18]
be a more effcient photosensitizer than the parent drug. Specifically, the enhance-
ment of intracellular calcium, lipid membrane peroxidation and oxidation of model
proteins (BSA, HSA) and RNASe suggests that fluvastatin and its photoproduct
affect mainly the cellular membrane by photosensitization (Figure 1.9) [20].
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Figure 1.9: Photosensitized protein oxidation by fluvastatin (grey) and its photoproduct (white)
at 11 J cm−2 UVA, and 10 µM of photosensitizer, monitored as carbonyl content. Figure from
reference [20]
In an earlier work, similar conclusions have been drawn in our group from
photochemical and photobiological studies of atorvastatin calcium (ATV, Figure
1.10). This statin agent of the second generation is one of the most frequently
prescribed drugs in the United States and in Europe. Natural sunlight irradiation
of ATV aqueous solution leads mainly to a photoproduct resulting from oxidation
of the pyrrole ring and cyclization of the stilbene-like structure of ATV to form
the phenanthrene derivative ppATV (Figure 1.10)[21].
The absence of a triplet-triplet absorption in ATV, revealed by laser flash
photolysis (LFP), discards the role of the parent drug as photosensitizer. By con-
trast, ppATV exhibits a triplet-triplet transient absorption at λmax= 460 nm with
a lifetime of 26 µs (Figure 1.11)[22].
This species is quenched by Trp giving rise to the formation of the tryptophanyl
radical derived from a Type I oxidation of the amino acid. Moreover, this photo-
10
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Figure 1.10: Structures of ATV and ppATV
Figure 1.11: Transient absorption spectrum of a deaerated methanolic solution of ppATV after
laser pulse from 5 to 50 µs. Inset: Normalized decay monitored at 450 nm of the transient
obtained with nitrogen-bubbled (black line) or aerated (gray line) solutions of ppATV. Adapted
from reference [22]
product is able to produce singlet oxygen as observed by electron paramagnetic
resonance (EPR) using TEMP as 1O2 trap (see also Chapter 6 for accurate use
of the TEMPO/EPR methodology). During this experiment, the typical TEMPO
signal is increasing steadily for irradiation in the presence of ppATV, while an
induction time is necessary in the case of ATV. This is in agreement with the
inability of ATV itself to act as singlet oxygen sensitizer. The longer irradiation
times, the increase of TEMPO signal can be explained by the photochemical con-
version of the drug into ppATV; thus, this compound may behave as a Type I
and/or Type II photosensitizer (Figure 1.12)[22].
From a photobiological point of view, processes involved in biomolecule pho-
tosensitization by ppATV have been established using tryptophan (Trp) as model
biological component because it can be oxidized both by Type I and Type II mech-
anisms. The time-dependent decrease of Trp fluorescence emission upon UVA-
irradiation in the presence of ppATV is in agreement with the amino acid degra-
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Figure 1.12: Time-dependent formation of TEMPO upon irradiation of aerated solutions of TEMP
in the presence of ATV (4) or ppATV (). Inset: TEMPO signals obtained after 30 min of
irradiation of a solution of ATV (gray line) and ppATV(black line).Adapted from reference [22]
dation. Moreover, the involvement of a type II mechanism is evidenced by the
significant enhancement of the reaction rate when the experiment is performed in
D2O, where 1O2 presents a much longer lifetime in comparison with water (Figure
1.13)[22].
Figure 1.13: Tryptophan photodegradation monitored as function of irradiation time: tryptophan
alone (), tryptophan and ppATV in water (•), and tryptophan and ppATV in deuterium oxide
as solvent (). Adapted from reference [22]
1.2.2 Phototoxicity of halogenated nonsteroidal antiinflam-
matory drugs
In this section, the photosensitivity induced by aryl radicals is presented
through the photoreactivity of carbazole derivatives. Two studies on nonsteroidal
antiinflammatory drugs (NSAID) are selected as examples. The first one deals
with phototoxicity of carprofen (CRP) based on the reactive aryl radical obtained
directly upon irradiation of the parent drug. The second example is centered on
diclofenac (DCF), whose photoreactivity toward biological components is ascribed
12
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to its photoproduct, which is in the origin of an aryl radical formation.
Photochemical studies performed on CRP shows that it suffers a dehalogena-
tion process leading to 2-(2-carbazolyl)propionic acid (ppCRP) as main photo-
product (Figure 1.14) [23].
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Figure 1.14: Photophysical and photochemical pathways of carprofen. Figure redrawn from
reference [23]
Kinetic studies performed by LFP shows that this process mainly occurs from
CRP triplet excited state, which exhibits a triplet-triplet absorption band at
λmaxca. 430 nm . Furthermore, a second transient, absorbing at λmax ca. 640 nm,
is formed; it corresponds to carbazolyl radical (R2N•) represented in Figure 1.15
[23].
Figure 1.15: Transient absortion spectra of a nitrogen-saturated PBS solution of CRP measured
after 150 ns (A) and 2000 ns (B). Plot C is the difference (A-B) to observe better CRP triplet
and e-(aq). Adapted from reference [23]
Photoreactivity of CRP toward biological targets has been evaluated first
through its ability to mediate photoperoxidation of linoleic acid. Upon irradiation,
an appreciable amount of dienic hydroperoxides is formed, this amount is higher
than that produced by tiaprofenic acid, another NSAID (Figure 1.16). By contrast,
13
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photoproduct ppCRP does not induce significant photoperoxidation. This can be
explained by abstraction of the double allylic hydrogen by CRP aryl radical, which
would be the initial step in a Type I radical chain reaction of linoleic acid. The
photohemolysis test gives similar results (Figure 1.17), and shows that CRP is
able to photosensitize lysis of the erythrocyte membranes, while its photoproduct
ppCRP has a slower lytic activity[23].
Figure 1.16: Photoperoxidation of linoleic acid sensitized by CRP (•), ppCRP ( ), and tiapro-
fenic acid (). Adapted from reference [23]
Figure 1.17: Photohemolysis of RBC sensitized by CRP (•) and ppCRP (). Adapted from
reference [23]
Finally, CRP photodehalogenation can also promote photobinding to the car-
rier protein human serum albumin (HSA). This photoadduct represents a hapten
and can consequently promote a photoallergic reaction. Again, CRP triplet ex-
cited state is the key species of this photoreaction as revealed by LFP quenching
experiments.
Diclofenac (2-(2,6-dichloroanilino)phenylacetic acid) gives rise to photosensi-
tivity disorders [24]. This has been confirmed by photopatch tests studies [25], as
14
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well as by the in vivo mouse tail technique[26]. Photodegradation of DCF yields
1-(8-chlorocarbazolyl)acetic acid (ppDCF) as the major photoproduct [24, 27]
(Figure 1.18).
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Figure 1.18: Photochemical pathways of diclofenac and its photoproduct. Figure redrawn from
reference [28]
For ppDCF, two transient species are observed by LFP (Figure 1.19). The
first one corresponds to the triplet excited state signal with an absorption band at
λmax ca. 430 nm and a lifetime of 270 ns, whereas the second transient peaking at
λmax ca. 640 nm was assigned to the corresponding carbazolyl radical (R2N•) by
analogy with other carbazoles (Figure 1.19)[29].
Figure 1.19: Transient absorption spectra of a nitrogen-saturated ethanol solution of ppDCF
measured at 200 and 900 ns after the pulse. Adapted from reference [28]
Irradiation of linoleic acid in the presence of ppDCF results in the formation
of dienic hydroperoxides (Figure 1.20). This can be explained by abstraction of the
double allylic hydrogen by either radical I or II (Type I mechanism). The kinetic
pattern observed for this process is in agreement with dehalogenation as the major
process involved in lipid peroxidation, as described above for CPF.
Similar conclusions can be made from the photohemolytic study: ppDCF and
15
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Figure 1.20: Photoperoxidation of linoleic acid sensitized by ppDCF (◦) and carprofen (a).
Adapted from reference [28]
CRP have a higher lytic activity than DCF (Figure 1.21). Thus, the photosensi-
tization activity of DCF seems to be associated with the photobiological activity
of its photoproduct, through the cleavage of its carbon-halogen bond.
Figure 1.21: Photohemolysis of RBC sensitized by DCF (), ppDCF (◦), other photoproduct
(
a
), and carprofen (
`
). Adapted from reference [28]
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Chapter 2
Aims
2.1 Aims
In this thesis, the attention will be focused on photosensitization by drugs
with the ultimate aim to provide a mechanistically based strategy that allows us to
get insights into the molecular mechanism. In this way, study of well-established
phototoxic drugs should provide helpful information on the mechanisms. This
knowledge could then be applied in the drug development process to design new
pharmaceutics with a higher photosafety. Such a strategy will include not only the
study of photophysical and photochemical properties of the drug alone but also in
the presence of biomolecules like lipids, proteins, DNA, and their simple building
blocks.
In this context, we propose the study of three representative photoactive drugs
(ie. rosuvastatin, itraconazole and imatinib) to gain information on the different
processes related to their photosensitivity side effects.
The following specific goals will be addressed in the present doctoral thesis:
1. To characterize the photophysical properties of the selected drugs. Specifi-
cally, to determine their properties in the ground state (absorption), in the
singlet excited state (steady state and time resolved fluorescence) and also in
the triplet excited state (by means of laser flash photolysis and phosphores-
cence).
2. To determine and quantify the formation of reactive oxygen species like singlet
oxygen during drug irradiation. To assess the limits of the TEMPO/EPR
method to achieve this goal.
3. To investigate the photostability of the drug. If photodegradation occurs,
to isolate and characterize the photoproducts and to determine their photo-
physical properties (see aims 1 and 2).
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4. To evaluate the parent drug (or photoproduct) photosensitizing potential
through investigation of its interaction with biomolecules or their building
blocks.
5. To propose a flow diagram to carry out the study of drugs (or xenobiotics)
with potential photosensitizing properties
2.2 Objetivos
En esta tesis se centrará la atención en la fotosensibilización promovida por
fármacos con el fin último de proporcionar una estrategia que nos permita obtener
detalles del mecanismo molecular. De esta manera, el estudio de fármacos conoci-
dos por ser fototóxicos debe proporcionar información útil sobre los mecanismos.
Este conocimiento puede ser aplicado en el proceso de desarrollo de moléculas para
el diseño de nuevos productos farmacéuticos con un menor riesgo fotoquímico.
Esta estrategia incluirá no sólo el estudio de las propiedades fotofísicas y foto-
químicas de la misma molécula, sino también el estudio de las mismas propiedades
en presencia de biomoléculas como lípidos, proteínas, ADN, y sus componentes.
En este contexto, se propone el estudio de tres fármacos fotoactivos represen-
tativos (es decir rosuvastatina, itraconazol e imatinib) para obtener información
sobre los diferentes procesos relacionados con sus efectos secundarios. Los sigu-
ientes objetivos específicos se tratarán en la presente tesis doctoral:
1. Caracterizar las propiedades fotofísicas del fármaco seleccionado. Mas especí-
ficamente, determinar sus propiedades en el estado fundamental (absorción),
así como en el estado excitado singlete (fluorescencia en el estado estacionario
y en tiempo resuelto) y también en el estado excitado triplete (por medio de
fotólisis de destello láser y fosforescencia).
2. Detectar y cuantificar la formación de especies reactivas de oxígeno como
el oxígeno singlete durante la irradiación de dichas moléculas. Dentro del
alcance de este objetivo, también se evaluarán los límites del método EPR/
TEMPO.
3. Evaluar las potenciales interacciones del fármaco original (o fotoproducto)
con biomoléculas o sus componentes.
4. Proponer un diagrama de flujo para aclarar los resultados del estudio de
dichos fármacos (o xenobióticos) con potenciales propiedades fotosensibi-
lizantes.
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Chapter 3
Phototoxicity of
Rosuvastatin∗
3.1 Introduction
In this chapter, the attention has been focused on rosuvastatin (RSV, Fig-
ure 3.1), a synthetic statin of third generation also known as “superstatin” for its
low IC50 (median inhibitory concentration) value for HMGR inhibition. Photol-
ysis of RSV has previously been studied in the literature; it leads to formation
of the stable dihydrophenanthrene-like products (ppRSV and ppRSV3) and to
the fully conjugated ppRSV4 compound (Figure 3.1)[30]. Indeed, the photore-
action mechanism has been paralleled with that established for 2-vinylbiphenyl
compounds, where photochemical electrocyclization leads to an unstable 8a,9-
dihydrophenanthrene intermediate, which then undergoes a thermal sigmatropic
1,5-hydrogen shift to yield dihydrophenanthrene (Figure 3.2)[31, 32].
The aim of the present work is to investigate the potential role as photo-
sensitizer of the drug RSV and of one of its photoproducts as photosensitizer,
through the study of their photophysical properties and their interaction with key
biomolecule building blocks. To achieve this aim, the following points have been
addressed:
1. Photophysics of the parent drug rosuvastatin
2. Photophysics of its main photoproduct ppRSV
3. Singlet oxygen generation by ppRSV
4. Interaction of ppRSV with biomolecule building blocks, thymidine (Thd)
for DNA and tryptophan (Trp) for proteins.
∗Reproduced in part with permission from: Potential Phototoxicity of Rosuvastatin Mediated
by Its Dihydrophenanthrene-like Photoproduct; Giacomo Nardi; Virginie Lhiaubet-Vallet; Paula
Leandro-Garcia; Miguel A. Miranda Chem. Res. Toxicol., 2011, 24, 1779-1785. Copyright
2011 American Chemical Society.
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Figure 3.1: Structures of rosuvastatin (RSV) and its photoproducts
Figure 3.2: Up, general intramolecular photocyclization of 2-vinylbiphenyl-like compound to yield
dihydrophenanthrene. Bottom, transient absorption spectra of 1-(o-diphenyl)-1-phenylethylene.
Dotted line: triplet absorption. Full line: cyclic intermediate. Figure adapted from ref [31]
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Figure 3.3: Absorption spectra of RSV 4.8×10−5 M () and ppRSV 1.5× 10−5 (◦) in PBS.
3.2 Results and discussion
3.2.1 Photophysics of rosuvastatin
Rosuvastatin absorption reaches the UVA region of the spectrum; it exhibits
a maximum at 243 nm and a shoulder until 350 nm (Figure 3.3). A very weak
fluorescence emission was observed at 373 nm (data not shown). This emission
was increasing during measurement of successive spectra with the same sample,
suggesting RSV degradation under UV-irradiation.
Photolability was further observed by laser flash photolysis (LFP) experiments
performed on N2-degassed PBS solutions of RSV. Indeed, after one laser pulse,
the decay monitored at 400 nm exhibited a remarkable change, suggesting forma-
tion of a new intermediate (Figure 3.4). Transient absorption spectrum of RSV,
obtained using a fresh sample for each point, showed a long-lived species centered
at ca. 550 nm (Figure 3.5). By comparison with literature data available for
2-vinylbiphenyl derivatives[31, 32] (Figure 3.2) this transient has been assigned
to the 8a,9-dihydrophenanthrene intermediate of RSV cyclization leading to the
dihydrophenanthrene-like compounds.
Moreover, LFP studies run on a RSV irradiated sample showed a signal with
maximum at 400 nm. This species was quenched by oxygen, and thus it was ten-
tatively assigned to the triplet excited state of RSV photoproduct(s). These re-
sults agree well with RSV photochemistry corresponding to an electrocyclization
process followed by a sigmatropic H transfer to form the primary photoproduct
ppRSV[30]. Moreover, the lack of triplet excited state detection and the low
fluorescence emission, indicate that RSV should be considered as an unlikely pho-
tosensitizer, as previously reported for ATV [22](for which a photoproduct rather
than the parent drug is in the origin of the photosensitized damage to biomolecules).
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Figure 3.4: LFP at 308 nm excitation of RSV (4.8×10−5 M) in PBS, decays monitored at 400
nm: after the first LFP pulse () and the second LFP pulse (◦).
Figure 3.5: Transient absorption spectra of RSV (4.8×10−5 M) in PBS solution, recorded using
a fresh solution for each laser pulse (Xe/Cl excimer, 308 nm excitation).
3.2.2 Photophysics of the major rosuvastatin photoproduct
As shown in Figure 3.6, ppRSV exhibits a defined absorption band centered
at λmax = 313 nm. It is noteworthy that the photoproduct has a stronger ab-
sorption in the UVA region than RSV, which thus increases its potential to act as
a photosensitizer under solar irradiation. Steady-state fluorescence of ppRSV in
ACN solution showed an emission spectrum with λmax at 376 nm and a fluorescence
quantum yield ΦF of 0.014, obtained using carprofen as standard (ΦF = 0.068)[23].
Fluorescence emission was not quenched by oxygen. A singlet-state energy
(ES) of 84 kcal mol−1 was determined by considering the intersection between the
normalized emission and excitation spectra (Figure 3.6). Similar results were ob-
tained using PBS and methanol as solvent (Table 3.1). Low temperature emission
was also measured in EtOH at 77K. Under these conditions, ppRSV showed a
well-defined emission spectrum with a maximum centered at 460 nm. A triplet
excited state energy value (ET (ppRSV)) of 69.2 kcal mol−1 was obtained from
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the 0 - 0 band of the spectrum.
Figure 3.6: Fluorescence excitation (◦, λem = 376 nm) and emission (, λexc = 314 nm) of
ppRSV in acetonitrile at 295 K. Phosphorescence emission spectrum in EtOH at 77 K (4, λexc
= 312 nm).
Laser flash photolysis of deaerated solutions of ppRSV showed a transient
at 400 nm (Figure 3.7) with lifetime varying from 8 µs in methanol to 20 µs in
PBS. This species was efficiently quenched by oxygen, and thus it was tentatively
assigned to ppRSV triplet excited state (3ppRSV) (Table 3.1). Interestingly, this
signal was similar to that observed during LFP of an irradiated sample of RSV
(see Figure 3.5).
Figure 3.7: Transient spectrum (from 2 to 20 µs) of triplet - triplet transition obtained for a
degassed acetonitrile solution of ppRSV (3.3×10−5 M) after 308 nm laser excitation.
The nature of ppRSV transient was confirmed by further quenching experi-
ments. In a first stage, a diffusion-controlled process was observed in the presence
of β-carotene (ET ca. 20 kcal mol−1). Under these conditions, the transient ab-
sorption at 400 nm disappeared concomitantly with the appearance of a new band
peaking at 520 nm, which corresponds to the characteristic T-T absorption of β-
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Solvent λem ES ΦF λT−T τT kq(O2)
(nm) (kcal mol−1) (nm) (µs) (M−1s−1)
PBS 368 84 0.036 400 20 1.2×109
MeOH 370 84 0.012 400 10 2.6×109
ACN 376 84 0.014 400 8 2.0×109
Table 3.1: Photophysical properties of ppRSV in different solvents
carotene. Thus, a triplet-triplet energy transfer is occurring, which agrees with the
triplet state nature of the 400 nm transient species (Figure 3.8).
Figure 3.8: LFP at 308 nm excitation of ppRSV (3.3×10−5 M) in deaerated ACN, transient decay
monitored at 400 nm without ()and in the presence of increasing concentration of β-carotene
(from 0 to 2.0×10−5 M). Inset: Transient absorption spectrum (from 1 to 5 µs) of triplet-triplet
transition obtained for a degassed acetonitrile solution of ppRSV (3.3×10−5 M) and β-carotene
(2.0×10−5 M) after 308 nm laser excitation.
A complementary experiment was also performed; it consisted in the quench-
ing of the triplet excited state of a donor using ppRSV as acceptor. Taking into
account the 3ppRSV energy value determined above, xanthone was used as a
suitable photosensitizer (ET = 73.2 kcal mol−1). As shown in Figure 3.9, xan-
thone triplet-triplet absorption centered at 630 nm was quenched in the presence
of ppRSV with a bimolecular rate constant of 1.6×1010 M−1s−1, thus confirming
on the one hand the triplet nature of the 400 nm transient and on the other hand
that ET (3ppRSV) is lower than ET (xanthone).
Further characterization of 3ppRSV was performed by determining the mo-
lar absorption coefficient of its triplet-triplet absorption in acetonitrile. The sig-
nals formed after quenching of xanthone triplet excited state by ppRSV or 1-
methylnaphthalene were compared, using the latter as standard (see experimental
section). In this way, a value of 8500 M−1cm−1 at 400 nm was obtained, and the
intersystem crossing quantum yield (ΦISC) was estimated at 0.8 by means of the
comparative method.
As explained in the introduction chapter, singlet oxygen (1O2) is one of the
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Figure 3.9: LFP at 355 nm excitation. Decays of xanthone (6.6×10−5 M in deaerated acetonitrile)
monitored at 630 nm, in the presence of increasing concentration of ppRSV (from 0 to 6.6×10−5
M). Inset: Stern-Volmer plot.
main reactive oxygen species (ROS) involved in the oxidative damage to living
systems. The efficient 3ppRSV quenching by molecular oxygen observed by LFP
should give rise to the formation of 1O2 by a triplet-triplet energy transfer process
(eq. 5, Figure 1.16). To confirm production of this species, spin trapping exper-
iments were conducted using the well-known conversion of TEMP to the stable
free radical TEMPO, detectable by EPR analysis (for more details see chapter 6).
A methanolic solution of TEMP was irradiated in the presence of ppRSV. As
shown in Figure 3.10, under these conditions, detection and increase of the typical
TEMPO signal as a function of irradiation time provided a clear evidence for the
role of ppRSV as singlet oxygen sensitizer.
Figure 3.10: TEMPO signals obtained by irradiation of a methanolic solution of TEMP (10 mM)
and ppRSV (3.3×10−5 M): without irradiation () and after 5 (s) and 7 (◦) min of irradiation
The quantum yield of 1O2 formation was determined by time-resolved near-IR
emission studies using naproxen as standard (Φ∆ = 0.27 in acetonitrile[33]). The
intensity of the characteristic singlet oxygen emission at 1270 nm was plotted as a
function of the laser intensity for oxygenated acetonitrile solutions of ppRSV and
naproxen. A quantum yield of 0.3 was obtained from the ratio of the linear plot
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slopes. The same value was obtained by registering steady state emission of 1O2,
using perinaphthenone as standard (Φ∆= 1 in acetonitrile [34])
All the photophysical properties of ppRSV could be summarized in the Figure
3.11. After promotion to its singlet excited state (eq. 1, Figure 1.16), ppRSV
can undergo different deactivation pathways, including fluorescence (eq. 2) and
intersystem crossing (eq. 3). Based on LFP experiments, an efficient triplet excited
state formation (ΦISC= 0.8) has been established. Moreover, a high triplet state
energy (ET = 69.2 kcal mol−1) has been determined by phosphorescence emission
studies (eq. 4). Indeed, triplet excited states have been demonstrated to be crucial
species in photosensitizing reactions [23, 33]. Thus, in connection with ppRSV
photophysical properties, three processes have been considered to investigate the
interaction between 3ppRSV and biomolecules (eq. 6-8, Figure 3.11).
Figure 3.11: Summary of all reactions involved in rosuvastatin phototoxicity promoted by its
photoproduct.
3.2.3 Interaction of ppRSV with biomolecules
Thymidine
In a first stage, interaction with DNA components was considered by monitor-
ing the 3ppRSV decay at 400 nm in the presence of increasing amounts of Thd.
As shown in Figure 3.12, addition of the nucleoside results in the shortening of
3ppRSV lifetime. A bimolecular quenching rate constant of 3.0×107 M−1s−1 was
determined from the Stern-Volmer plot (Figure 3.12, inset).
The involved mechanism that corresponds to a triplet-triplet energy trans-
fer from ppRSV to thymidine (Thd, equation 6 of Figure 3.11) could give rise to
thymidine cyclobutane dimers (Thd<>Thd), an important DNA lesion[35] (Figure
3.13). Mechanism of photosensitization could be outlined as follows: after absorp-
tion of light, the photosensitizer reaches its singlet excited state and is subsequently
promoted to its triplet excited state. Then, the triplet excited state of Thd is pop-
ulated through a triplet-triplet energy transfer process. This state can react with
26
3.2. RESULTS AND DISCUSSION
Figure 3.12: LFP at 308 nm excitation of ppRSV (3.3×10−5 M) in deaerated PBS, transient
decay monitored at 400 nm without () and with 10−3 M Thd (◦). Inset: Stern - Volmer plot.
another molecule of Thd in its ground state (0Thd) to form a cyclobutane thymi-
dine dimer. As a requirement for this process to occur, the triplet state energy of
the photosensitizer has to be higher than that of the DNA base. Few compounds
are known to exhibit the appropriate properties to act as efficient sensitizers. In
this context, the ET value of 3ppRSV , determined as 67 kcal mol−1, is high
enough to make this compound a potential Thd<>Thd photosensitizer, in fact
3ppRSV triplet excited state lies close to that of benzophenone or carprofen, both
reported as Thd<>Thd photosensitizers. Indeed, the obtained value is in agree-
ment with expectations from the triplet energy gap between donor and acceptor[35].
Figure 3.13: Schematic representation of photosensitized formation of thymidine dimer.
Tryptophan
Related studies were also performed with a protein building block. Specifically
Trp represents an interesting probe as it can be oxidized both by Type I and Type
II mechanisms. In this context, the oxidizing potential of 3ppRSV has been eval-
uated by means of time-resolved and steady-state experiments. Direct interaction
of 3ppRSV with Trp has been studied by LFP. Quenching by this amino acid (Fi-
gure 3.14) was found to occur with a bimolecular rate constant of 5.0×107 M−1s−1,
leading to formation of the long-lived tryptophanyl radical (λmax at 310 and 520
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nm)[36]. This is in agreement with a mechanism involving electron transfer from
Trp to 3ppRSV, followed by deprotonation of the resulting radical cation at pH
= 7.4, to form the tryptophanyl radical [36].
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Figure 3.14: LFP at 308 nm excitation of ppRSV (3.3×10−5 M) in deaerated PBS, transient
decay monitored at 400 nm without () and with 5×10−6 M (4) Trp. Inset: Transient absorption
spectrum of ppRSV in the presence of 1.8 ×10−5 M Trp registered 2, 10, 60 µs after the laser
pulse.
In addition, the ppRSV photoreactivity was investigated by steady-state pho-
tolysis of ppRSV at 320 nm in the presence of equimolar amounts of Trp. The
disappearance of the amino acid fluorescence emission (λmax= 353 nm) with ir-
radiation time was observed and taken as measurement of the extent of oxidation
(Figure 3.15). To check the involvement of a type II mechanism, a parallel experi-
ment was performed in D2O, where the lifetime of 1O2 is longer than in water. As
a matter of fact, a significant enhancement of the reaction rate was observed under
these conditions, in agreement with Trp oxidation by 1O2.
This result is in accordance with the ppRSV singlet oxygen quantum yield Φ∆
of 0.3 (eq. 5, Figure 3.11). In addition, a Type I reactivity has also been evidenced
by LFP. Indeed, 3ppRSV quenching by Trp (eq. 7, Figure 3.11) leads to formation
of the tryptophanyl radical arising from an electron transfer process. Therefore,
oxygen and Trp compete for 3ppRSV quenching. The predominance of Type I
or Type II mechanism can be inferred from the absolute quenching rates (kq×[Q])
that not only consider the bimolecular rate constant kq but also the concentration
of the quencher [Q]. Thus, considering the maximum quencher concentration used
in this work (i.e. 1.3×10−3 M and 20×10−6 M for oxygen and Trp, respectively),
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Figure 3.15: (A) 1.8 ×10−5 M Tryptophan fluorescence emission (λexc= 282 nm) with an equimo-
lar concentration of ppRSV, recorded at increasing irradiation time. (B) Tryptophan photodegra-
dation. Normalized emission at λem = 353 nm monitored as a function of irradiation time: Trp
alone in PBS (), and Trp in the presence of equimolar amounts of ppRSV (2×10−5 M) in PBS
(◦) and in deuterium oxide as solvent (4).
a Type II / Type I ratio of 14 is obtained. Although this value only reflects the
competition between processes (5) and (7) of Figure 3.11 and does not take into
account the subsequent steps, it clearly indicates that Trp is mainly decomposed
by a singlet oxygen process.
3.3 Conclusion
It has been demonstrated that rosuvastatin, a photolabile UV-absorbing statin,
presents the appropriate properties of an efficient photosensitizer, acting through
photoproduct formation. The attention has been placed on RSV main photo-
product (ppRSV). Indeed, the photobehavior of this dihydrophenanthrene-like
compound presents the essential components needed for an efficient biomolecule
photosensitizer i.e. (i) a high intersystem crossing quantum yield (ΦISC = 0.8),
(ii) a triplet excited state energy of ca. 67 kcal mol−1, and (iii) a quantum yield of
singlet oxygen formation of 0.3. Furthermore, laser flash photolysis studies reveal a
triplet - triplet energy transfer from the triplet excited state of ppRSV to thymi-
dine, leading to the formation of cyclobutane thymidine dimers, an important type
of DNA lesion. Finally, tryptophan has been used as a probe to investigate the
Type I and / or Type II character of ppRSV - mediated oxidation. On the basis of
the obtained results, rosuvastatin, through its major photoproduct ppRSV, should
be considered as a potential sensitizer and might be in the origin of undesired side
effects like phototoxicity and/ or photogenotoxicity.
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3.4 Experimental part
In this section the specific experimental procedure for this chapter is described.
General experimental procedures, like UV-Vis absorption spectra or emissions, are
described in detail at the general experimental chapter 7.
3.4.1 Chemicals
Rosuvastatin was purchased from KEMPROTEC Limited and was used with-
out further treatment. 2,2,6,6-Tetramethylpiperidine (TEMP) and β-carotene were
purchased from Fluka. Deuterated water (D2O), xanthone, carprofen (CRP),
naphthalene (NP), naproxen, perinaphthenone, L-tryptophan (Trp), thymidine
(Thd), 1-methylnaphthalene (MeNP) and benzophenone (BP) were from Sigma
Aldrich. The reagent grade solvents were obtained from Scharlau and used with-
out further purification. Phosphate buffered saline (PBS) solutions of 0.01 M (pH
= 7.4) were prepared by dissolving tablets (Sigma-Aldrich) in Milli-Q water.
3.4.2 Photochemical synthesis of ppRSV
Compound ppRSV was isolated as previously described in the literature [30].
Briefly, a dispersion of rosuvastatin calcium (75 mg in 150 mL of water) was irra-
diated for 20 min in Pyrex tubes using the photoreactor equipped with six lamps.
The irradiation mixture was dried under vacuum and separated by silica gel TLC-
chromatography eluting with CH2Cl2/MeOH (95:5) with drops of acetic acid (two
runs) to obtain the diastereometric mixture of ppRSV. All of the experiments were
conducted at room temperature and under air atmosphere. The 1H and 13C NMR
spectral data were identical to those previously reported[30]. Although the two
diastereoisomers obtained can be chromatographically separated, the photophys-
ical and photobiological experiments were performed with the diastereoisomeric
mixture.
3.4.3 LFP experiments
Photosensitization of ppRSV triplet excited state by xanthone was performed
using 355 nm excitation wavelength, whereas determination of ppRSV triplet ex-
cited state properties (lifetime, intersystem crossing quantum yield, interaction
with biological compounds etc. . .) was done exciting at 308 nm. In the case of
rosuvastatin LFP was also performed with 308 nm laser.
A modified energy transfer methodology was used to determine the molar absorp-
tion coefficient of triplet-triplet transition of ppRSV ((3ppRSV400)). It consists in
the quenching of xanthone triplet excited state (λ = 633 nm) by ppRSV or 1-me-
thylnaphthalene, used as standard. Molar absorption coefficient of 3ppRSV was
obtained from the ratio of ∆A of ppRSV (at λ= 400 nm) and 1-methylnaphthalene
(at λ= 415 nm) when more than 95% of xanthone triplet was quenched. The fol-
lowing equation was used:
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(3ppRSV400) = (3MeNP415)× ∆A(
3ppRSV400)
∆A(3MeNP415)
(3.1)
where ∆A(3ppRSV400) and ∆A(3MeNP415) refer to the transient absorption
of ppRSV and 1-methylnaphthalene triplet state (at 400 and 415 nm, respec-
tively) at the end of the process, and (3MeNP415) corresponds to the known
molar absorption coefficient of the 1-methylnaphthalene triplet at 415 nm ( =
11200 M−1cm−1 in acetonitrile[37]).
Then, intersystem crossing quantum yield (ΦISC) was determined by the com-
parative method taking into account the amount of 3ppRSV and naphthalene pop-
ulated after 308 nm laser excitation. Isoabsortive degassed acetonitrile solutions
of both compounds were used. So, (ΦISC) was obtained by using the following
equation:
ΦISC(3ppRSV ) = ΦISC(3NP )× ∆A(
3ppRSV400)
∆A(3NP420)
× (
3NP420)
(3ppRSV400)
(3.2)
where ΦISC(3NP ) corresponds to the intersystem crossing quantum yield of
naphthalene; (3NP420) refers to the molar absorption coefficient of naphthalene
triplet at 420 nm;
∆A(3ppRSV400) and ∆A(3NP420) refer to the transient absorption of 3ppRSV
and NP triplet at 400 and 420 nm, respectively. The values of (3NP420) and
ΦISC(3NP ) in acetonitrile were taken as 15000M−1cm−1 and 0.8, respectively[38].
3.4.4 Singlet oxygen measurements
All measurements were made at room temperature, under air atmosphere, us-
ing acetonitrile as solvent in 1 cm pathway quartz cuvettes. The absorbance of the
samples was 0.30 at the laser wavelength. The singlet oxygen quantum yield (φ∆)
was determined using naproxen in acetonitrile (φ∆=0.27) as standard [33]. Singlet
oxygen formation was calculated from the slope of the plots of signal intensity at
zero time versus laser light intensity according to the following equation:
φ∆(sample) =
Isample
Istandard
× φ∆(standard) (3.3)
where Isample is the emission intensity for the sample,
Istandard is the emission intensity for the standard and φ∆(standard) is the standard
quantum yield of singlet oxygen formation.
3.4.5 EPR trapping experiments
Analysis was performed with the EPR spectrometer described in chapter 7
recording the EPR signal of the free radical TEMPO generated by reaction of
singlet oxygen with TEMP [39]. Aerated methanolic solutions of 10 mM TEMP
containing ppRSV, with an absorbance of 0.3 at 300 nm, were irradiated in a
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multilamp photoreactor equipped with 300 nm centered lamps; the EPR spectra
were recorded at different irradiation times.
3.4.6 Tryptophan photodegradation
PBS solution of ppRSV (2 ×10−5M) containing an equimolar concentration
of tryptophan were irradiated at 320 nm using a MicroBeam system (see chapter
7. Tryptophan fluorescence emission intensity (λex = 282 nm, λem = 353 nm) was
recorded at increasing irradiation time. A parallel experiment was performed under
identical conditions using deuterium oxide as the solvent. A solution of tryptophan
in PBS (2 ×10−5M) was used as control.
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Chapter 4
Phototoxicity of
Itraconazole∗
4.1 Introduction
4.1.1 Itraconazole and its photoadverse effects
Itraconazole (1, Figure 4.1) belongs to the azole family of antifungal agents.
This relatively safe and orally bioavailable drug is a broad-spectrum triazole deriva-
tive, which generally shows a lower toxicity than the imidazole antifungals. As a
matter of fact, it represents an important therapeutic option in the treatment
against dermatophytes, dimorphic fungi in the skin, some molds and also against
dermatomycosis of glabrous skin. The pharmacological activity of 1 relies on its
ability to inhibit specifically the fungi cytochrome P450 14-α-sterol demethylase,
responsible for demethylation of lanosterol, blocking this way the synthesis of ergos-
terol, an essential component of the fungi membrane (Figure 4.2). Ergosterol syn-
thesis inhibitors suppress fungal cell growth under most circumstances (fungistatic
effect), and they can sometimes cause fungal cell death (fungicidal effect). Recently,
1 has also demonstrated a selective inhibitory activity against multiple aspects of
angiogenesis associated with non small cell lung cancers[40, 41].
Among the adverse effects of antifungal triazole drugs, some medical cases of
photosensitivity as skin responses upon exposure to sunlight have been reported
to occur on skin exposed areas; they correspond to: erythema, oedema and vesi-
cles on sun-exposed areas, but also visual disturbances (as photophobia or blurred
vision).[42–45]
∗Generation of reactive aryl radical intermediates in the reductive photodehalogenation
of itraconazole ; Giacomo Nardi; M. Luisa Marin; Pierre A. de Souza; Virginie Lhiaubet-
Vallet; Miguel A. Miranda; RSC Adv., 2014, 4, 2687-2693 (http://pubs.rsc.org/en/content/
articlelanding/2014/ra/c3ra43644f) - Reproduced by permission of The Royal Society of
Chemistry (RSC)
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Figure 4.1: Structure of itraconazole (1) and its photoproducts 2-4.
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Figure 4.2: Ergosterol synthesis pathway: cytochrome P450 14α-sterol demethylase is inhibited
by 1
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However, in spite of their wide use as antifungal agents, the photobehavior of
these azole drugs has been scarcely investigated[46–49].
In this context, itraconazole has been selected here to investigate whether free radi-
cals arising from a photodehalogenation process may be responsible for the observed
in vivo photosensitivity responses[50]. As a matter of fact, the 2,4-dichlorophenyl
moiety of 1 presents some photochemical similarities with the photolabile non-
steroidal antiinflammatory drugs carprofen or diclofenac (see introduction chap-
ter). Both suffer a photodechlorination that leads to undesired photobiological
effects, as revealed by the photohemolysis of red blood cells and photodynamic
lipid peroxidation[23, 28, 50].
In the present chapter, the photophysical and photochemical studies of this
drug have been addressed; this includes steady state photolysis, fluorescence and
phosphorescence spectroscopies, as well as photoreactivity in the presence of bio-
logical models.
4.2 Results and discussion
4.2.1 Photophysical properties of itraconazole
The absorption spectrum of 1 was recorded in different solvents in order to
evaluate its capability to absorb in the different regions of the UV spectrum. As
shown in Figure 4.3, 1 exhibits a main band with maximum at ca. 260 nm and a
tail reaching the UVB region. The position of the maximum was weakly dependent
on the solvent; it was shifted from 262 nm in methanol to 266 in dichloromethane
(Figure 4.3 and Table 4.1).
After confirming the itraconazole absorption properties as possible photosen-
sitizer, its excited states were investigated. Steady-state fluorescence of 1 showed
a very weak emission centered at λmax = 376 nm in methanol (Figure 4.4). It
corresponds to a singlet excited state energy (ES) of 85 kcal mol−1, which was
determined by considering the intersection between the normalized emission and
excitation spectra (λ0−0). Similar results were obtained using CH2Cl2 or acetoni-
trile as solvents (Table 4.1). The fluorescence quantum yields (ΦF ) reported in
Table 4.1 were determined using carprofen as standard (ΦF = 0.068 in acetoni-
trile). The obtained values of ca. 0.01 showed that emission is not the preferred
deactivation pathway of the singlet excited state. Thus, crossing to the triplet ex-
cited state has been studied next as a potential deactivation pathway.
In this context, low temperature phosphorescence emission was also performed
in ethanol at 77 K. Under these conditions, the phosphorescence spectrum of 1
showed a band with maximum at 421 nm (Figure 4.4). Thus, a triplet excited
state energy value of ca. 75 kcal mol−1 was obtained. Laser flash photolysis of 1
was also run to gain information on its triplet excited state at room temperature;
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Figure 4.3: Absorption spectra of 1 in different solvents: MeOH (solid squares), acetonitrile
(circles) and dichloromethane (triangles).
Solvent λmax ε λem ES ΦF
(nm) (M−1 cm−1) (nm) (kcal mol−1)
CH2Cl2 266 37000 370 89 0.010
MeOH 262 35500 376 85 0.013
ACN 264 36000 379 85 0.012
Table 4.1: Photophysical properties of 1 in different solvents
however, no transient species were observed. The absence of detectable triplet
excited states suggests that the deactivation pathway could be related to the pho-
toreactivity of the molecule.
4.2.2 Photochemistry of itraconazole
Photoproducts
After investigating the photophysical behavior of 1, its photostability was ad-
dressed. For this purpose, aerated acetonitrile solutions of the drug were UVB
irradiated, and the course of the reaction was followed by HPLC. In spite of its
moderate absorption above 290 nm, 1 suffered a significant photodegradation, as
observed in the typical HPLC chromatogram shown in Figure 4.5. Three pho-
toproducts were mainly formed. These compounds were isolated by preparative
HPLC, and characterized by NMR and HRMS (see appendix A). Their mass spec-
trometric analysis revealed the typical isotopic pattern of monochlorinated com-
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Figure 4.4: Normalized excitation spectra of 1 in MeOH (solid squares, λem = 376 nm), fluores-
cence emission (circles, λexc = 262 nm). Phosphorescence emission spectrum in EtOH at 77 K
(triangles, λexc = 262 nm).
pounds. The structure of 2 was assigned on the basis of the molecular ion obtained
at m/z 669.2704, which corresponds to the loss of HCl from the parent drug, to-
gether with the 1H and 13C NMR spectra, which are in agreement with formation
of a new six membered ring (Figure 4.6). The other two main photoproducts were
also found to result from a dehalogenation process. They were assigned to 3 and 4
(Figure 4.1), which correspond to reductive dechlorination in ortho (Figure 4.7) and
para position (Figure 4.8), respectively (both with m/z 671.2861). In these last two
cases, the change of the hyperfine structure of the aromatic part of the spectrum,
due the replacement of Cl with H, is quite clear. In fact, in compound 3 there is
a more symmetric distribution of signals at 7.40-7.20 due to the Cl substitution
in para position. While in compound 4, doublets change to doublet of doublets
due to the presence of a second small coupling constant in the aromatic ring . In-
terestingly, cyclized compound 2 prevailed over the ortho- and para-dechlorinated
products 3 and 4, which were obtained in smaller amounts (Figure 4.9).
Mechanistic hypothesis
Thus, 1 was found to be photolabile, and its exposure to UVB light resulted
in consumption of the drug by a photodechlorination process leading to three pho-
toproducts (Figure 4.1). From a mechanistic point of view, the weak fluorescence
emission, together with the low energy of the triplet excited state compared to
the carbon-chlorine bond dissociation energy (ca. 95 kcal mol−1) and the lack of
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Figure 4.5: HPLC pattern obtained during UVB irradiation of 1 in acetonitrile. The peaks are
marked with the numbers corresponding to the structures given in Figure 4.1.
Figure 4.6: 1H-NMR differences between 1 and 2: disappearance of triazole hydrogen signal at
8.40 ppm and shift of the phenyl hydrogens
quenching by oxygen point to the involvement of the singlet excited state. The
resulting phenyl radical (1•) would abstract hydrogen from acetonitrile or undergo
an intramolecular reaction leading to alkylation of the triazole moiety, giving rise
to the formation of 2 (see Figure 4.10A). The poor mass balance indicated a sub-
stantial degree of polymerization. Photodegradation quantum yield of 1 was found
to be 0.20.
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Figure 4.7: 1H-NMR differences between 1 and 3: Substitution of chlorine atom at second position
of phenyl ring by a hydrogen atom leads to a more symmetric distribution of the phenyl signals.
Figure 4.8: 1H-NMR differences between 1 and 4: Substitution of chlorine atom at position 4
of the phenyl ring by a hydrogen atom is revealed by the appearance of doublets with hyperfine
structure.
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Figure 4.9: Relative areas of 1 and its photoproducts 2,3,4 determined by HPLC (monitored at
254 nm), plotted as a function of reaction time. Irradiations were performed in ACN under UVB
irradiation.
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Figure 4.10: (A) Mechanistic scheme for photodecomposition of 1 in different media. (B) Potential
photoreactivity of 1 with biomolecules.
4.2.3 Type I photooxidation mediated by itraconazole
The whole scenario could change in the presence of good H donors, as illus-
trated in the literature for the nonsteroidal antiinflammatory drugs carprofen and
diclofenac [23, 28]. In these cases, photodechlorination was proposed to be the
key process from a toxicological point of view. Thus, C-Cl cleavage would be the
source of highly reactive radicals, which for carprofen and diclofenac (through its
cyclized photoproduct) were demonstrated to be in the origin of photohemolysis
and photodynamic lipid peroxidation. In fact, aryl radicals are able to abstract hy-
drogen from lipids, mediating their peroxidation by a Type I mechanism[23, 28, 50].
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To check this possibility, irradiation of 1 was performed in ethanol, under
air, as model for biological media with H-donating ability. Unfortunately, ethanol-
water mixtures could not be used, for solubility limitations. The kinetics of drug
photodegradation in ethanol, shown in Figure 4.11, revealed a much lower degree
of polymerization and a change in photoproducts distribution. Indeed, 3 was now
formed as the major product, whereas markedly smaller amounts of the cyclized
compound 2 were obtained (Figure 4.11). These results are in agreement with
the potential for H abstraction of radical 1•, a process which leads mainly to the
reduced compounds 3 and 4. This strongly suggests that itraconazole could act
as a Type I photosensitizer towards biomolecules, being potentially in the origin
of harmful photobiological processes like lipid photoperoxidation, photohemolysis,
and oxidative damage to DNA or protein.
Figure 4.11: Relative areas of 1 and its photoproducts 2,3 and 4 determined by HPLC (monitored
at 254 nm), plotted as a function of reaction time. Irradiations were performed in EtOH under
UVB irradiation.
4.2.4 Dyads as biomodels
Dyads are useful models to evaluate the effects of stereochemistry, inter-
chromophore distances, diffusion or steric hindrance. Here, two cases of dyads
combining a drug moiety and a biological component have been selected to illus-
trate their usefulness to go deep into the mechanistic detail of photosensitization,
especially for Type I process.
The first case deals with photooxidation of α-cholesterol (αCh) or β-cholesterol
(βCh) by ketoprofen (KP). The importance of steric effects has been demonstrated
by the lack of photoreactivity of the β-Ch-KP dyad due to the extended confor-
mation between the two parts. By contrast, the α isomer is highly reactive and
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Figure 4.12: Dyad KP-αCh and formation of photoproduct upon photolysis.
gives rise to two cyclic photoproducts through H-abstraction from H7 of αCh by the
npi∗ triplet excited state of KP and recombination of the obtained biradical (Figure
4.12). Moreover, a clear difference has been observed between the two isomers of
KP. In fact, the dyad between R-(KP) and α-cholesterol was more photoreactive
than dyad with the S-isomer [51].
As a second example, carprofen (CRP) is able to photobind HSA. In this
case the candidate substrate for the reaction is the tryptophan (Trp) amino acid
located in site I pocket of the protein. To mimic this reaction, a dyad between
the drug and tryptophan has been studied (Figure 4.13). Fluorescence and LFP
experiments have revealed the occurence of an electron transfer between Trp and
excited CRP. Moreover, a stereodifferentiation has been evidenced, with a higher
reactivity for the R-CRP isomer [52] .
4.2.5 Photobinding of itraconazole to model
biomolecules
As mentioned above, irradiation of 1 in acetonitrile leads to a primary pho-
todehalogenation process followed by radical cyclization onto the triazole moiety.
This reaction pathway is reminiscent of covalent photobinding between drugs and
proteins, which is the triggering step of photoallergy[53–55]. Thus, the attention
was focused on the ability of radical 1• to react with proteins, and in particular
with the aromatic amino acid residues, for instance the indole heterocycle of Trp.
With this aim, a model dyad (5) was designed by linking Trp methyl ester with 2,4-
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Figure 4.13: Dyad CRP-Trp.
dichlorophenylacetic acid, which contains the reactive moiety of 1 (Figure 4.14).
As a matter of fact, steady state photolysis of aerated acetonitrile solutions of 5 at
the absorption maximum (230 nm), gave rise to formation of a major photoproduct.
Its analysis by HRMS revealed a m/z 369.1002, which corresponds to the loss of
HCl. After isolation by preparative HPLC and analysis by NMR spectroscopy (1H,
13C NMR and HMQC), the structure was unambiguously assigned to the cyclized
compound 6 (Figure 4.15). These findings reveal that the aryl radical generated
upon homolysis of the C-Cl bond in the dihalophenyl moiety of 1 can in principle
arylate reactive amino acid residues of proteins leading to the formation of covalent
photoadducts.
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Figure 4.14: Photoreactivity of the model dyad 5.
Overall, itraconazole has demonstrated to be photolabile under UVB irradi-
ation. The study of its photochemical and photophysical properties has provided
mechanistic insight into the reported in vivo photosensitivity side effects[42].
Thus, characterization of the photoproducts has revealed a primary dehalo-
genation process taking place mainly from the ortho position of the dihalogenated
phenyl moiety. As detailed in Figure 4.10A, in a poor hydrogen donating medium
as acetonitrile the generated radical 1• attacks the triazole ring to form a cyclized
intermediate, which finally gives rise to compound 2. Essentially, a parallel behav-
ior would be expected in aqueous medium, in the absence of a hydrogen source.
Conversely, the presence of a good hydrogen donor (RH, Figure 4.10A) disfavors the
cyclization process; in this case, the main reaction pathway corresponds to H ab-
straction by 1•, leading mainly to formation of the ortho-dechlorinated compound
3.
From a toxicological point of view, the photosensitization mechanisms may
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Figure 4.15: DEPT 13C NMR of 5 and 6: disappearance of CH signal due the cyclization at the
C2 position of indole moiety.
involve a direct interaction between drugs and biological substrates (Type I) or
energy transfer from their triplet state to molecular oxygen, generating singlet
oxygen (Type II). In this case, the latter process seems unlikely, since the triplet
excited state of 1 was not detected by laser flash photolysis. However, the reac-
tivity of radical 1• is relevant for its potential to act as a type I photosensitizer
(Figure 4.10B), and indeed, its capability to photooxidize biological targets like
lipids, DNA or proteins is strongly suggested by the observed H-abstraction from
ethanol. Direct reaction of 1• with oxygen seems unlikely, in view of the short life-
time of aryl radicals and the moderate concentration of oxygen in aerated solutions
(in the mM range). After formation of biomolecule-derived radicals (B•), reaction
with oxygen would lead to unstable peroxides (BOO•) and ultimately to oxidation
of the biological substrate. Such a process, already reported in the literature for
structurally related compounds (DCF or CRP), has been recognized to be re-
sponsible for drug-induced phototoxicity (see Introduction chapter). Alternatively,
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radical 1• could attack a suitable biomolecule component, to form a covalent bond.
This type of drug-protein photoaddition (1-B, Figure 4.10B) was anticipated from
radical attack to the triazole ring giving rise to the cyclized photoproduct 2. Exper-
imental evidence supporting this mechanism was obtained by the study of model
dyad 5, where a primary dehalogenation step leads to formation of a covalent bond
between the dihaloaromatic reactive moiety and the tryptophan ring, giving rise
to compound 6. In line with this result, photobinding of the nonsteroidal antin-
flammatory agent carprofen to human serum albumin has been identified as the
key photochemical process involved in the photoallergy elicited by this drug[52, 56].
4.3 Conclusions
The present study has demonstrated the potential of antifungal azoles as pho-
tosensitizers of biomolecules. Itraconazole is not stable under UVB irradiation.
Its photodehalogenation leads to formation of a biologically reactive aryl radical,
which could be in the origin of the itraconazole potential to induce phototoxicity
by a Type I photooxidation process or photoallergy through covalent photobinding
to proteins.
4.4 Experimental part
In this section the specific experimental procedure for this chapter are de-
scribed. General experimental procedures, like UV-Vis absorption spectra or emis-
sions, are described in detail at the general experimental chapter 7 .
4.4.1 Chemicals
Itraconazole (1), 2,4-dichlorophenylacetic acid and L-tryptophan methyl ester
were from TCI Europe. N’-(3-Dimethylaminopropyl)-N-ethylcarbodiimide hydro-
chloride (EDC), 1-hydroxybenzotriazole (HOBt), N-methyldiphenylamine (MDPA)
and carprofen (CRP) were from Sigma-Aldrich. MDPA was distilled under reduced
pressure before using it. The reagent grade solvents were obtained from Scharlau
and used without further purification.
4.4.2 Photolysis of 1
Irradiation of 1 (5 mg/mL) was performed in ethanol or acetonitrile, under
aerobic atmosphere, by means of a multilamp photoreactor equipped with UVB
lamps (Hitachi, F15T8/BL, maximal output at ca. 300 nm). The photoreactions
were monitored by high-performance liquid chromatography using a reverse phase
column (C18 Mediterranea, 25 × 1.0 cm, acetonitrile/water, 60/40, v/v). A fixed
wavelength of 254 nm was used for detection.
Degradation quantum yield of 1 was determined using MDPA as an external acti-
nometer (Φ = 0.45 in acetonitrile) [57, 58]. Freshly prepared aerated solution of
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1 and MDPA in acetonitrile (4 mL quartz cells) were irradiated in parallel using
monochromatic 300 nm light (A300 = 0.50), by means of a Microbeam system
(model L-201), including a 150 W xenon lamp coupled with a monochromator
(model 101). Aliquots were collected at different irradiation times and analyzed
by HPLC (detection 262 nm). Concentration versus irradiation time plots were
obtained using additional calibration curves. Then, degradation quantum yield of
1 (Φ1) was determined from the ratio of the slopes of the degradation profiles,
according to eqn (4.1)
Φ1 =
Slope1
SlopeMDPA
× ΦMDPA (4.1)
Where Slope1 and SlopeMDPA correspond to the linear fittings of the concen-
tration versus time irradiation experiments and ΦMDPA is the degradation quan-
tum yield of the reference.
4.4.3 Isolation and identification of photoproducts 2-4
Isolation of the photoproducts was carried out using a reverse phase column
C18 Kromasil 100, 25 × 2.5 cm, acetonitrile/water, 60/40, v/v. Ammonium hy-
droxide was added at every collected fraction until pH 9, and then the fractions
were dried at reduced pressure. Characterization was achieved by NMR and HRMS
analysis (see appendix A).1H and 13C NMR spectra of the parent drug have been
previously described in the literature[59].
4.4.4 Synthesis of the model dyad 5
2,4-Dichlorophenylacetic acid (75 mg, 3.65 ×10−4 mol), L-tryptophan methyl
ester (108 mg, 4.26×10−4 mol), EDC (81.7 mg, 4.26 ×10−4 mol), and HOBt (200
mg, 4.26 ×10−4 mol) were mixed in dry DMF (10 mL), and the mixture was
stirred overnight. Then, the solution was treated with 10% HCl and extracted
with ethyl acetate. The organic phase was washed 3 times with water and twice
with saturated sodium bicarbonate and then dried over sodium sulfate. The residue
was dried under vacuum to give a yellowish solid. Characterization was performed
by means of NMR and HRMS (ESI+) analysis.
4.4.5 Isolation and identification of photoproduct 6
Compound 5 (1.460 g, 3.6 ×10−3 mol) was dissolved in acetonitrile/water 2/1,
v/v (400 mL), and irradiated under aerated conditions at 230 nm for 45 min (Mi-
crobeam L-201 system including a 150 W Xe lamp and a L-101 monochromator).
Next, the solution was concentrated under vacuum and re-dissolved in ethyl ac-
etate. The organic phase was washed with brine and concentrated. Isolation of
the main photoproduct was performed by column chromatography with a gradient
of hexane/ethyl acetate; final purification was carried out using a reverse phase
column (C18 Kromasil 100, 25×2.5 cm), using acetonitrile/water, 60/40, v/v as
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eluent. Characterization was performed by means of NMR and HRMS (ESI+)
analysis.
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Chapter 5
Photosensitization by
Imatinib∗
5.1 Introduction
Imatinib (IMT, Figure 5.1) is a first line therapy agent that specifically targets
tyrosine kinases, which are central proteins in the pathogenesis of human cancer[60–
63]. This promising drug (Gleevecr or Glivecr), approved by the FDA in 2001,
was designated as a “magic bullet” and was recognized for its capacity to deal with
fatal cancers converting them into manageable chronic conditions[60–62, 64]. It is
widely prescribed for the treatment of Philadelphia chromosome-positive chronic
myeloid leukemia (CML) or gastrointestinal stromal tumors (GIST) and has also
proven its efficacy in other neoplastic diseases[60–63]. It has been reported that
IMT inhibits three tyrosine kinases with a high degree of specificity: the Abel-
son cytoplasmic tyrosine kinase (Abl) activated in CML, the c-Kit tyrosine kinase
for GISTs and some melanomas, and the platelet derived growth factor receptors
(PDGFR) kinase [63, 65]. Tyrosine phosphorylation of proteins involved in signal
transduction and initiation of the cascade responsible for cancer development are
prevented, interrupting this way the growth of cancer cells[62].
Interestingly, IMT has emerged from rational drug design based on in vitro
assays, in a successful attempt to optimize the chemical structure on the basis
of isolated protein kinase inhibition [62, 64, 65]. The first step allowed identify-
ing 2-phenylaminopyrimidine as an inhibitor of hyperactive Abl protein by high
throughput screening of chemical libraries. Afterwards, this lead compound, which
exhibited low potency and poor specificity but constituted an attractive scaffold
for further development, was optimized by the attachment of a 3-pyridyl group
at the C4 position of the pyrimidine in order to improve cellular activity. Sub-
∗Reproduced in part with permission from: Photosensitization by imatinib. A photochemical
and photobiological study on the drug and its substructures, Giacomo Nardi; Virginie Lhiaubet-
Vallet; Miguel A. Miranda, Chem.Res.Toxicol., 2014, 27, 1990-1995. Copyright 2014 American
Chemical Society.
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Figure 5.1: Structure of IMT and some of its potentially photoactive substructures
sequently, introduction of a benzamide moiety led to a modest activity against
Abl and PDGFR tyrosine kinases, which was markedly enhanced by appending
a methyl group at the C6 position of the aniline ring. Finally, solubility, oral
bioavailability, metabolism and excretion were improved by introduction of the N-
methylpiperazine side chain[62, 64, 65].
Cutaneous reactions are among the most common nonhematological side ef-
fects of IMT [66–70]. They include increased photosensitivity[66, 71, 72], photoin-
duced dermatitis[72], pseudoporphyria[68, 69, 73], or squamous cell carcinoma[74].
The occurrence of these adverse effects only in long-term treated patients suggests
that the cumulative dosage is determinant for photosensitization[71]. However,
the molecular bases have not been unveiled yet, and different scenarios have been
proposed. One of them is that IMT impairs melanogenesis via inhibition of c-Kit
enzyme activity, thereby leading to hypopigmentation and thus altering the natu-
ral skin protection against UV exposure[66, 68, 71]. Drug-induced photosensitivity
has also been associated with ATP-binding cassette transporter ABCG2 inhibition
leading to accumulation of endogenously produced porphyrins and pheophorbide
A in the systemic blood circulation [75, 76]. Interestingly, photodynamic therapy
studies have taken advantage of this apparent drawback by coadministering IMT,
thus allowing photosensitizer accumulation in tumor cells[77].
In the case of photosensitizing drugs, their intrinsic photoreactivity and their
excited state interactions with key biomolecules are of paramount importance.
However, to our knowledge only one work has previously dealt with IMT pho-
tobehavior, reporting a remarkable photostability after 72 h of light exposure[78].
This is surprising, as the drug contains potentially photoactive moieties such as the
anilino-pyrimidine and the pyridyl-pyrimidine substructures (framed in green and
red, respectively, Figure 5.1). The former is closely related to pyrimethanil, a pho-
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tolabile fungicide whose irradiation gives rise to formation of eight photoproducts[79],
whereas the latter should also be photoreactive by analogy to biphenyl and its
derivatives, which exhibit well-characterized singlet and triplet excited states and
a solvent-dependent intersystem crossing quantum yield[38, 80, 81].
With this background, the aim of the present work is to investigate the photo-
behavior of IMT and its main building blocks, with special emphasis on the DNA
photosensitizing potential. For this purpose, IMT and its model compounds 1
and 2 (Figure 5.1) have been submitted to steady-state and time-resolved fluores-
cence, as well as laser flash photolysis (LFP) studies. Formation of DNA damage
has been examined by detection of single strand breaks (SSB) using agarose gel
electrophoresis.
5.2 Results and discussion
5.2.1 Photogenotoxicity of imatinib and its substructures
In order to evaluate the potential of IMT, 1 and 2 as DNA photodamaging
agents, supercoiled DNA (pBR322) was UVA-irradiated in the presence and in
the absence of the three compounds. After agarose gel electrophoresis, the native
supercoiled (Form I) was separated from circular DNA (Form II) resulting from
single strand breaks (SSB). As shown in Figure 5.2, DNA Form II increased with
irradiation time in the presence of 2, whereas no significant changes were observed
in the case of 1, IMT or the DNA control. These results reveal that the drug itself
is not a DNA-photosensitizer, while one of its substructures displays a marked
photogenotoxic potential.
Figure 5.2: Agarose gel electrophoresis of supercoiled DNA (pBR322, 20 µM) irradiated for 0-30
min alone and in the presence of 1, 2 or IMT (220 µM)
5.2.2 Photophysical studies
The attention was first focused on the photophysical properties of the par-
ent drug. As shown in Figure 5.3, its absorption spectrum exhibits two maxima
peaking at 230 and 275 nm, together with a tail reaching the UVB-UVA region.
This long-wavelength absorption is an important requirement for photosensitiz-
ing agents, as it is responsible for their interaction with solar radiation. Indeed,
light absorption leads to population of excited states that can mediate damage
to biomolecules. However, neither the singlet nor the triplet excited state could
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be detected by fluorescence or LFP measurements, respectively (data not shown).
This is consistent with the lack of DNA-photosensitization by IMT.
Figure 5.3: UV absorption spectra of IMT (black) and compounds 1 (green) and 2 (red) in
acetonitrile
Then, the photophysical properties of the substructures, starting with 2-phe-
nylaminopyrimidine (1) were considered. The absorption spectrum displayed a
main band centered at ca. 270 nm together with a shoulder extending up to ca.
350 nm (Figure 5.3). The fluorescence emission was characterized by a maximum
at ca. 445 nm (Figure 5.4A). A singlet excited state energy (ES) of ca. 78 kcal
mol−1 was obtained from the intersection between normalized emission and exci-
tation spectra. Moreover, transient absorption spectra obtained after LFP (308
nm, Xe:Cl excimer laser) revealed the presence of two bands (Figure 5.5A). The
minor species with a maximum at 360 nm and a lifetime of 10 µs in deaerated ace-
tonitrile was weakly quenched by oxygen (kq= 7.3×107 M−1s−1). By contrast, the
major, long wavelength band starting at 500 nm and extending beyond 700 nm was
much shorter-lived (0.34 µs), and its quenching by oxygen occurred much faster
(kq= 6×109 M−1s−1); hence, it was tentatively assigned as a triplet excited state
(31∗). In order to confirm the nature of this transient, parallel experiments were
performed in the presence of biphenyl and β-carotene (βC) as energy acceptors;
their triplet energies are ET= 65 kcal mol−1 and 20 kcal mol−1, respectively[38].
The former does not absorb 308 nm light, whereas the latter has an extremely
inefficient intersystem crossing (ΦT<0.001)[38]; thus under the employed LFP con-
ditions the triplet excited states can only be populated by photosensitization. In
both cases, typical triplet bands were indeed observed (Figure 5.5B) after nearly
diffusion-controlled energy transfer from 31∗ (kET= 10×1010 M−1s−1). Moreover,
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as shown in Figure 5.5C, the growth of the characteristic 3βC∗ signal matched
with the decay of 31∗. Overall, the above results allowed safe assignment of the
long wavelength transient absorption as 31∗, whose energy must be above that of
biphenyl.
Figure 5.4: Fluorescence emission (full line) and excitation (dotted line) spectra of compound 1
at λexc =280 nm (A) and compound 2 at λexc = 328 nm (B) in acetonitrile solution
Thus, compound 1 is capable of generating a potentially photoactive triplet
excited state; however it does not show a significant photogenotoxic potential in the
SSB assay. This can be attributed to the short lifetime (submicrosecond) of 31∗.
Interestingly, during optimization of IMT design it has been demonstrated that
introduction of a 6-methyl group, denominated the flag methyl, affects the confor-
mation of the molecule[82]. This change is associated with a better specificity of
IMT by suppressing the inhibition of serine/tyrosine kinases while enhancing that
of the PDGF kinase. From a photophysical point of view, this structural change led
to blocking of the fluorescence emission and to the absence of any transient species
in the LFP spectrum (data not shown), resulting in an enhanced photosafety.
Finally, the photobehavior of compound 2 was addressed. The absorption
spectrum obtained in acetonitrile displayed two main bands, one in the UVC at
240 nm and the other one in the UVB/UVA region peaking at ca. 320 nm (Figure
5.3). The emission measurements revealed a maximum at ca. 390 nm (Figure 5.4B),
and a fluorescence quantum yield of 0.23 using pyrene (ΦF= 0.72) as standard[38].
A singlet excited state energy ES= 81 kcal mol−1 was determined from the in-
tersection between the excitation and emission bands (Figure 5.4B). As regards
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Figure 5.5: (A) Transient absorption spectra of compound 1 in deaerated acetonitrile obtained
at different times after the laser pulse at 308 nm. (B) Transient absorption spectra 0.8 µs after
the laser pulse of 1, in the presence of 1500 µM biphenyl (black) or 33 µM β-carotene (blue). (C)
Decay at 700 nm and growth at 520 nm for a solution of 1 in the presence of β-carotene (33 µM)
LFP (Figure 5.6A), transient absorption spectra of 2 in acetonitrile exhibited two
bands at 320 and 420 nm, which decayed with the same lifetime of ca. 5 µs. This
species was ascribed to the triplet excited state (32∗) based on its photosensitized
formation from xanthone (Figure 5.6B) and on its efficient quenching by oxygen
and βC (Figure 5.6C).
Thus, compound 2 is photoactive and possesses a long-lived triplet excited
state that can be associated with undesired photosensitization effects. This ex-
plains the photogenotoxic potential of 2 observed in the SSB assays. Being a
substructure of IMT, one could in principle anticipate that the drug itself could
also exhibit similar photochemical and photobiological properties as 2; however,
this was not confirmed by the experimental results. Clearly, the integration of 2 in
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Figure 5.6: (A) Transient absorption spectra of 2 in N2-bubbled acetonitrile at different times
after 308 nm laser excitation. (B) Decays of xanthone triplet excited state monitored at 612 nm
in the presence of increasing amounts of 2 (from 0 to 84 µM). Inset: Corresponding Stern-Volmer
plot. (C) Growth of the 520 nm signal upon quenching of 32∗ by 13 µM βC. Inset: spectra
obtained after 0.40 (red) and 0.65 (black) µs
a more complex structure strongly modifies its photobehavior, which in this case
is fortunate because it leads to an improved toxicological profile. In order to gain
some insight into this intriguing observation, the possibility of an internal quench-
ing was investigated by checking whether the key active species 32∗ could exhibit
significant excited state interactions with benzanilide 3 (Figure 5.7A), another sub-
structure of IMT. Indeed, when LFP of 2 was run in the presence of increasing
concentrations of 3, a consistent shortening of the triplet lifetime was measured,
clearly indicating dynamic quenching (Figure 5.7B).
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Figure 5.7: (A) Structure of compound 3 and its relationship to IMT. (B) Decays of 32∗ moni-
tored at 420 nm in the presence of increasing amounts of 3 (from 0 to 23 µM). Inset: Corresponding
Stern-Volmer plot
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5.3 Conclusions
Imatinib is a tyrosine kinase inhibitor, which has found application in the
treatment of some types of cancer. It constitutes a successful example of ratio-
nal design through appropriate molecular engineering. The chemical structure of
this drug contains different fragments that are combined to enhance the phar-
macological activity and the pharmacokinetic behavior. As regards the toxicolo-
gical profile, imatinib has been reported to mediate some undesired side effects,
including adverse cutaneous reactions such as enhanced photosensitivity or pseu-
doporphyria. In this context, two of its substructures are photoactive, namely the
aniline-pyrimidine (1) and the pyridyl-pyrimidine (2) moieties. The latter displays
a long-lived triplet excited state and exhibits photogenotoxic potential, revealed
through photosensitization of single strand breaks in supercoiled DNA. Interest-
ingly, imatinib does not show the photochemical and photobiological behavior of
its substructures. Specifically, it does not give rise to a detectable triplet state
and does not mediate DNA photodamage. This is attributed to internal quenching
of the excited pyridyl-pyrimidine chromophore by the benzanilide fragment. On
the bases of the obtained experimental results, direct in vivo photosensitization
by imatinib seems unlikely. Instead, the reported photosensitivity disorders could
be related to indirect processes, such as the previously suggested impairment of
melanogenesis or the accumulation of endogenous porphyrins.
5.4 Experimental part
In this section the specific experimental procedure for this chapter are de-
scribed. General experimental procedures, like UV-Vis absorption spectra or emis-
sions, are described in detail at the general experimental chapter 7.
5.4.1 Chemicals
All reagents were purchased either from Sigma-Aldrich Co. or Kemprotec, Inc.
and were used without further purification. Compounds 1 and 2 were obtained as
described[83, 84], whereas compound 3 was synthesized with a procedure adapted
from the literature[85]. Synthesis and characterization of those compound are
described at appendix B.
5.4.2 Agarose gels
The detailed procedure followed for agarose gel electrophoresis has been de-
scribed elsewhere[86]. Samples containing supercoiled circular DNA (pBR322; 5
µL; 20 µM of base-pairs) in the absence or presence of IMT, compound 1 or 2 (5
µL; 220 µM) were used in the electrophoresis experiment. The samples were irra-
diated using a multilamp photoreactor (Luzchem) with fluorescent tubes emitting
in the 300-400 nm range with a maximum at 355 nm (LZC-UVA). The samples
were then loaded on a 0.8% agarose gel containing RedSafer.
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Chapter 6
Scope and limitations of the
TEMPO/EPR method for
singlet oxygen detection: the
misleading role of electron
transfer∗
6.1 Introduction
Singlet oxygen (molecular oxygen in a 1∆g state or 1O2) is one of the most
important reactive oxygen species (ROS). Its reactions include oxidation of lipids
[6, 87], proteins [88–90] and nucleic acids [5, 91, 92], that may trigger a biological
damage. This may lead to undesired adverse effects, like drug phototoxicity [4, 93],
but it can also be exploited to produce beneficial effects as in photodynamic ther-
apy [94, 95].
Production of 1O2 by a photosensitizer is a classical example of photoinduced
energy transfer: after absorption of light, the photosensitizer reaches its singlet
excited state and subsequently crosses to its triplet excited state. Then, the triplet
ground state of molecular oxygen (3Σg) is promoted to the 1∆g state through
triplet-triplet energy transfer[96].
For many biological and biomedical studies, it is essential to detect the pro-
duction of 1O2 and its quantification. Among the available methods, detection
∗Reprinted from: Scope and limitations of the TEMPO/EPR method for singlet oxygen detec-
tion: the misleading role of electron transfer, Giacomo Nardi; Ilse Manet; Sandra Monti; Miguel
A. Miranda; Virginie Lhiaubet-Vallet, Free Radic. Biol. Med., 2014, 77, 64-70. Copyright
2014, with permission from Elsevier.
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of the characteristic 1270 nm phosphorescence of singlet oxygen by time resolved
near infrared (TRNIR) emission constitutes the most direct and unambiguous proof
[97, 98]. However, the required equipment is not always available in biochemical
laboratories.
An alternative (indirect) method that has been widely applied is the use of
electron paramagnetic resonance (EPR) in combination with trapping. Upon reac-
tion with 1O2 , the trap molecule gives rise to a detectable spin active species with a
distinctive line pattern. Thus, detection of TEMPO (2,2,6,6-tetramethyl-1-piperi-
dinyloxyl) free radical can be easily achieved by EPR after the oxidation of TEMP
(2,2,6,6-tetramethylpiperidine) with singlet oxygen (Figure 6.1) [39]. Although the
TEMPO/EPR method has been largely employed [22, 99–106], a systematic inves-
tigation of the scope and limitations of this technique has never been performed,
so it is feasible to obtain misleading data. For instance, a possible source of ar-
tifacts is the interaction between the excited photosensitizer and TEMP, which is
related to the widely described quenching of photosensitizers by amines[1, 107–109].
Figure 6.1: Structure of the molecules involved in the study and EPR signal of TEMPO radical.
The aim of the present study is to compare the results obtained by the direct
detection (TRNIR method) and by indirect spin trapping (TEMPO/EPR method)
for the detection and quantification of singlet oxygen, using a set of well-known pho-
tosensitizers. The basis of the TEMPO method and the chemical structure of the
selected photosensitizers are shown in Figure 6.1. The obtained results reveal that
the method leads to significant overestimation of singlet oxygen production when
the singlet or triplet excited state of the photosensitizers are efficiently quenched
by TEMP, acting as electron donor.
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Φ∆ a/ TRNIR Φ∆ /EPR
Phenalenone 0.95 b 0.95 b
Benzophenone 0.35 (0.35) c 0.50
Naphthalene 0.56 (0.5) d 0.50
Carbazole 0.15 (0.17) e 0.21
a in brackets, literature values, b as standard
see ref [34] c from ref [111] d from ref [110]
e from ref [23]
Table 6.1: Singlet oxygen quantum yield of each photosensitizer
6.2 Results and discussion
6.2.1 Determination of singlet oxygen quantum yield by TRNIR
or TEMPO/EPR
Singlet oxygen quantum yields (Φ∆) were determined for each photosensitizer
with both direct method (TRNIR) and indirect method (TEMPO/EPR), by com-
parison with phenalenone (φ∆= 0.95)[34](Figure 6.2). The obtained values are
reported in Table 6.1. The results of TRNIR direct method are in accordance
with literature values [23, 110, 111]. However, the quantum yield of benzophenone
evaluated by indirect method TEMPO/EPR was significantly higher. Moreover,
upon addition of 50 mM TEMP to the benzophenone solution, the direct TRNIR
measurement led to nearly zero quantum yield (Figure 6.2B and Figure 6.3A).
6.2.2 Effect of added TEMP on singlet oxygen detection by
TRNIR
To investigate the direct effect of TEMP addition on 1O2 detection, TRNIR
was performed with increasing amounts of TEMP. As shown in Figure 6.3, in
the absence of TEMP the 1O2 lifetime was 85 µs, using either phenalenone or
benzophenone as photosensitizers, in accordance with the literature value [112].
Depending on the photosensitizer, addition of TEMP to the solution had different
consequences: (i) in the case of phenalenone, TEMP acted as a poor quencher,
shortening the lifetime of 1O2 with kq = 1.3×106 M−1s−1 [113], a result consistent
with the literature value, or (ii) in the case of BP in addition to lifetime shortening,
TEMP was able to knock out the formation of singlet oxygen (Figure 6.3A). The
latter observation indicates that there is an interaction between TEMP and the
precursor of 1O2 , namely the excited triplet state of BP. In the case of PN,
addition of TEMP did not seem to influence the initial TRNIR intensity of 1O2,
while it affected the 1O2 lifetime (Figure 6.3B).
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Figure 6.2: Aerated ACN solution of PN (red), BP (blue), NP (green) and CBZ (cyano). (A)
Intensity of TEMPO in EPR as a function of irradiation time at 280 nm. In black, ACN solution
of 50 mM TEMP. (B) Initial intensity of 1O2 TRNIR signal as a function of 266 nm laser energy.
In black, solution of BP and 50 mM TEMP.
6.2.3 Quenching of photosensitizer excited states by TEMP
In view of the effects produced by addition of TEMP on 1O2TRNIR signal,
the triplet-triplet transient absorption of the photosensitizers was studied by laser
flash photolysis in presence of TEMP. In the case of BP, triplet quenching by
TEMP was observed with a rate constant (kq = 1.5×109 M−1s−1 ) in accordance
with literature [114, 115]. In the case of PN, although TEMP was also able to
deactivate the triplet excited state, the measured rate constant was two orders of
magnitude lower (kq = 8.3×106 M−1s−1). On the contrary, the rate constants for
triplet quenching by oxygen were very similar for the two ketones (ca. 2.5×109
M−1s−1 ). Taking into account the competition between TEMP and O2, as well as
the kq values and the TEMP and O2 concentrations (50 mM and 1.9 mM, respec-
tively), more than 90% of triplet BP is quenched by TEMP, whereas more than
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Figure 6.3: Decay of 1O2 at 1270 nm in aerated ACN solution of (A) BP, (B) PN with 0 mM
TEMP (black), 5 mM TEMP (red), 50 mM TEMP (blue). Incident 355 nm laser energy: 3.65
mJ/pulse, Abs355 = 0.3.
90% of triplet PN is quenched by O2 under the employed conditions. This fact
explains the difference between BP and PN in the singlet oxygen formation yields
upon TEMP addition.
As regardsNP andCBZ, weak intensity of the LFP signals makes their triplet
states to be barely detected in the presence of TEMP (see appendix C; this was
attributed to scarce population of the triplet states caused by quenching of the
precursor singlet excited states. To check this hypothesis, the emission signal of
NP and CBZ was monitored in the presence of TEMP. The results for CBZ are
shown in Figure 6.4A; they reveal a marked decrease of the fluorescence intensity
concomitant with the growth of a new structured emission band with peaks at 400,
420, 450 and 470 nm. This type of long-wavelength emission has been previously
observed in the presence of amines and attributed to charge transfer in the excited
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state (excitedCBZ carbanion and/or exciplex formation) [116]. The kq determined
by means of steady-state and time-resolved emission measurements were 9.1×108
M−1s−1 and 6.7×108 M−1s−1, respectively. The difference between the two val-
ues suggests the contribution of static quenching, probably due to formation of a
ground-state complex.
Figure 6.4: (A) Steady state fluorescence spectra of CBZ in aerated ACN solution with increasing
amount of TEMP. [CBZ] = 3.5×10−5M, λex = 331 nm. [TEMP] = 0 (black), 10 (red), 50 (blue),
100 mM (green). Inset: Decay of CBZ at 341 nm in aerated ACN solution with 0 mM TEMP
(black), 50 mM TEMP (blue). (B) Steady state fluorescence spectra of NP in aerated ACN
solution with increasing amount of TEMP. [NP] =2.3×10−6 M, λex = 278 nm. [TEMP] = 0
(black), 10 (red), 50 mM (blue). Inset: Decay of NP at 320 nm in aerated ACN solution with 0
mM TEMP (black), 50 mM of TEMP (blue).
Likewise, the singlet excited state of NP was quenched by TEMP (Figure
6.4B); the rate constant obtained from steady state fluorescence (kq = 1.9×109
M−1s−1) was similar to that resulting from time resolved fluorescence (kq = 2.0×109
M−1s−1), indicating that NP-TEMP ground-state complex can be safely ruled out.
It should be noticed that the efficient quenching of the excited photosensitizer by
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TEMP and the reduced 1O2 production are not reflected in the EPR measurements
of Table 6.1. Overall, the results related to excited state quenching by TEMP
suggest the possibility of an alternative electron transfer reaction pathway for the
oxidation of TEMP that produces a detectable TEMPO signal from TEMP, not
involving singlet oxygen.
6.2.4 Electron transfer oxidation of TEMP to TEMPO
Photoinduced electron transfer (PET) is a feasible reaction between ketone or
aromatic hydrocarbon photosensitizers and amines [1, 107–109]. Being a secondary
amine, TEMP (Eox= 1.0 V vs SCE)[117] could be oxidized by PET if the process
is thermodynamically allowed. According to Rehm-Weller [3], this requirement is
fulfilled for all the investigated photosensitizers. Indeed ∆G for electron transfer
is in all cases negative, being of ca. -10, -70, -30 and -70 kJ mol−1 for PN, BP,
NP and CBZ, respectively. To actually prove that an electron transfer reaction
can contribute to the production of the TEMPO radical, TEMP was oxidized by
tris(4-bromophenyl)aminium hexachloroantimonate (also named BAHA or magic
blue), a known one-electron oxidizing agent (Ered = 1.17 V vs SCE) [118]. Addition
of BAHA to a solution of TEMP in acetonitrile led to the bleaching of the initial
blue color, which turned pale brown. The resulting solution was analyzed by EPR,
and an enhanced TEMPO signal was observed under aerobic conditions. The
mechanistic scheme explaining these results is outlined in Figure 6.5. Generation
of the radical cation TEMP+• is followed by deprotonation and reaction of the
resulting neutral radical with molecular oxygen, finally leading to the TEMPO
radical [119–121].
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Figure 6.5: Proposed mechanism for the electron tranfer oxidation of TEMP to TEMPO in the
presence of molecular oxygen.
6.2.5 The case of rose Bengal, an archetypal 1O2 photosen-
sitizer
The methodology was applied to rose Bengal (RB), a 1O2 photosensitizer
widely used in cellular experiments. Steady-state fluorescence showed an almost
unaltered emission of RB singlet excited state in the presence of 100 mM TEMP
(Figure 6.6A). This result is in accordance with time-resolved measurements, which
allowed determining a very low quenching rate constant of ca. 107 M−1s−1 (Figure
6.6A, inset). Likewise, the triplet excited state of RB was not affected by the
presence of the secondary amine (Figure 6.6B). Thus, from these data one can an-
ticipate that the RB singlet oxygen quantum yield obtained by the TEMPO/EPR
method should correlate well with that reported in the literature (Φ∆ = 0.54)[122].
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Figure 6.6: (A) Emission of an aerated ACN solution of RB alone (black) or in the presence of
100 mM TEMP (blue). [RB]= 4×10−6 M, λex= 560 nm. Inset: Stern-Volmer plot obtained
from time-resolved measurements of RB in the presence of increasing amounts of TEMP (λex=
560 nm, λem=573 nm). (B) T-T absorption decays monitored at 620 nm (λex= 532 nm) of
argon-bubbled ACN solution of RB (3.3×10−5M) alone (black) or in the presence of 100 mM
TEMP (blue). (C) Area of TEMPO signal in EPR as a function of irradiation time at 280 nm,
A280= 0.4.
This was confirmed by performing the EPR experiment using PN as standard,
which led to a very reasonable value of 0.56 (Figure 6.6C).
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6.3 Conclusion
Detection and quantification of singlet oxygen by means of the TEMPO/EPR
method is a useful and widely employed technique. This method however may
be misleading when the excited photosensitizer is capable to react with TEMP,
acting as an electron donor. In this case, generation of the TEMP+•radical cation,
followed by deprotonation and reaction with molecular oxygen, gives rise to a EPR
detectable TEMPO signal that is not associated with singlet oxygen production.
The possibility of such an electron transfer interference can be anticipated by means
of simple thermodynamic calculations based on redox potentials and excited state
energies. In addition, this source of artifacts can be safely ruled out when no
quenching of the photosensitizer singlet and triplet excited states by TEMP is
observed in fluorescence and laser flash photolysis experiments, respectively. Thus
the application of such relatively simple techniques provides knowledge that is
essential for an appropriate and error-free application of the TEMPO/EPR method
of singlet oxygen detection in chemical, biological and medical studies.
6.4 Experimental part
In this section the specific experimental procedure for this chapter are de-
scribed. General experimental procedures, like UV-Vis absorption spectra or emis-
sions, are described in detail at the General experimental chapter 7.
6.4.1 Chemicals
2,2,6,6-Tetramethyl-1-piperidine (TEMP), tris(4-bromophenyl)aminium hexa-
chloroantimonate (BAHA), phenalenone (PN), benzophenone (BP), naphthalene
(NP), carbazole (CBZ), rose Bengal (RB) and acetonitrile (ACN) were from
Sigma-Aldrich. TEMP was freshly distilled at 152◦C before use.
6.4.2 Steady state fluorescence quenching
Quenching of CBZ and NP fluorescence intensity by TEMP upon excitation
at 331 and 278 nm, respectively, was performed by adding increasing amounts of
TEMP to the solution. The following equation was used to determine KSV , the
Stern-Volmer quenching constant:
F0
F
= 1 +KSV [Q] (6.1)
F0 and F are the fluorescence intensities in the absence and presence of the
quencher Q, respectively; [Q] is the quencher concentration (M), KSV (M−1) the
Stern-Volmer constant. The bimolecular quenching rate constant kq (M−1s−1) was
obtained dividing KSV by the fluorescence lifetime.
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6.4.3 Fluorescence lifetimes
Fluorescence decays were measured in air-equilibrated solutions with a time-
correlated single photon counting apparatus (IBH 5000F) equipped with a TBX
picosecond photon detection module. A NanoLED pulsed excitation source at 331
and 278 nm was used and the emission was collected at right angle at 341 or 320
nm using a long pass cutoff filter at 305 nm. Fluorescence decay profiles were fitted
using a monoexponential function of the decay analysis software DAS6 provided
by the manufacturer with deconvolution of the instrumental response function.
6.4.4 Singlet oxygen time-resolved near infrared (TRNIR)
emission measurements
All measurements were made at room temperature in 1 cm pathway quartz
cuvettes. The absorbance of the samples was 0.30 at the laser wavelength. The
singlet oxygen quantum yield (Φ∆) was determined using phenalenone in acetoni-
trile (φ∆(standard)=0.95)[34] as reference. Singlet oxygen formation quantum yield
was calculated from the slope of linear plots representing signal intensity at zero
time versus laser pulse energy according to the following equation:
φ∆(sample) =
Isample
Istandard
× φ∆(standard) (6.2)
where Isample is the emission intensity for the sample, Istandard is the emission
intensity for the standard and φ∆(standard) is the standard quantum yield of singlet
oxygen formation.
6.4.5 EPR trapping measurements
The EPR signal of the free radical TEMPO (g = 2.0060, aN = 17.3 G) gener-
ated by reaction of singlet oxygen with TEMP was recorded [123]. The measure-
ments were performed in a Wildman Suprasil/aqueous quartz ware flat cell (volume
of 150 µL, 60 mm of length) with a Bruker EMX 10/12 EPR spectrometer, using
the following parameters: microwave power, 20 mW; modulation amplitude, 1.0
G; and modulation frequency, 100 kHz. Aerated ACN solutions of 50 mM TEMP
containing a photosensitizer, with an absorbance of 0.4 at 280 nm, were irradiated
using the light produced by a Microbeam system (model L-201), including a 150
W xenon lamp coupled with a monochromator (model 101); EPR spectra were
recorded at different irradiation times. The singlet oxygen quantum yield (Φ∆)
was determined using phenalenone in acetonitrile (φ∆(standard)=0.95)[34]) as refer-
ence. Singlet oxygen formation was calculated from the slope of the plots of signal
area versus irradiation time according to the following equation:
φ∆(sample) =
Xsample
Xstandard
× φ∆(standard) (6.3)
where Xsample is the coefficient of linear fit for the sample, Xstandard is the
coefficient of linear fit for the reference and φ∆(standard) is the quantum yield of sin-
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glet oxygen formation of the reference. In the case of tris(4-bromophenyl)aminium
hexachloroantimonate (BAHA) oxidation, EPR spectra of aerated ACN solutions
of 50 mM TEMP were recorded before and after addition of 0.1 BAHA equivalents.
6.4.6 Photoinduced electron transfer
According to Rehm-Weller[3] the free energy change ∆G for electron transfer
is expressed by:
∆G = Eox − Ered − E∗ + C (6.4)
where Eox is the oxidation potential of the donor, Ered the reduction potential
of the ground state acceptor, E∗ the energy of the acceptor excited state and C
is a coulombic term accounting for the electrostatic attraction of the produced
ions. Neglecting the C term, ∆G was calculated using the following values for the
potentials: Eox (TEMP) = 1.0 V and Ered = -1.2, -1.3, -2.6 and -1.8 V vs SCE
for PN [124], BP[102], NP [125] and CBZ [112], respectively. In the case of PN
[113] and BP [102], the lowest triplet excited state energy was considered for E∗
with values of 220 and 292 kJ mol−1, respectively, whereas this parameter was
associated with the singlet manifold for NP [125] and CBZ [23], using values of
377 and 344 kJ mol−1, respectively.
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Chapter 7
General experimental
procedures
In this chapter, experimental procedures and standard equipment used in the
investigation chapters are described:
7.1 Photoreactors
Irradiations were performed by means of a multilamp photoreactor equipped
with lamps with a maximal output at ca. 300 nm (Hitachi, F15T8/BL). In the
case of monochromatic irradiation, a Microbeam system (model L-201), including
a 150 W Xenon lamp coupled with a monochromator (model 101), was used.
7.2 UV-Vis absorption spectroscopy
Absorbances of the samples were measured with a double beam Varian UV-VIS
model Cary 300 Scan spectrophotometer, using 1 cm pathway quartz cuvettes.
7.3 Fluorescence and phosphorescence emissions
The steady-state fluorescence experiments were carried out on a Photon Tech-
nology International (PTI) LPS-220B spectrofluorometer. Fluorescence quantum
yield measurements were performed with aerated methanol, acetonitrile and PBS
solutions; the absorbance was adjusted to ca. 0.1 at the excitation wavelength ,
and carprofen was used as standard (ΦF= 0.068 in acetonitrile)[23]. All measure-
ments were recorded using 1 cm pathway quartz cells with 4 mL capacity and were
carried out at room temperature.
Phosphorescence spectra were obtained from a Photon Technology Interna-
tional (PTI, TimeMaster TM-2/2003) spectrofluorometer equipped with a pulsed
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Xe lamp. The apparatus was operated in time-resolved mode, with a delay time of
0.5 ms. Compounds of interest were dissolved in ethanol, put in a quartz tube (5
mm of diameter) and cooled at 77K.
7.4 Laser flash photolysis (LFP)
Two laser flash photolysis systems were employed for the studies. For 355 nm
and 266 nm excitation, experiments were carried out using the 3rd or 4th harmonic
of a Quantel pulsed Nd:YAG spectrum laser system instrument. The single pulses
were ca. 10 ns duration, and the energy was ca.15 mJ/pulse. A pulsed Excimer
Laser Systems with Xe/HCl mixture was used for excitation at 308 nm. The single
pulses were 17 ns duration, and the energy was less than 100 mJ/pulse.
For both excitation systems, a Xenon lamp was employed as the detecting
light source. The laser flash photolysis apparatus consisted of the pulsed laser,
the Xe lamp, a monochromator, and a photomultiplier (PMT) system made up of
side-on PMT, PMT housing, and a PMT power supply. The output signal from
the Tektronix oscilloscope was transferred to a personal computer for study. All
transient spectra were recorded using 1×1 cm2 quartz cells with 4 mL capacity
and solutions were bubbled for 10 min with N2 or O2, before acquisition. The
absorbance of the samples was kept in the range 0.30-0.40 at the laser wavelength.
Stock solutions of quenchers were prepared so that it was only necessary to add
microliter volumes to the sample cell to obtain appropriate concentrations of the
quencher. A linear quenching plot was obtained, and the resulting rate constant
was calculated from the slope of the Stern-Volmer plot
kobs = k0 + kq[Q] (7.1)
where k0 is the triplet decay rate constant in the absence of quencher, kq is the
triplet decay rate constant in the presence of the quencher, and [Q] is the quencher
concentration in mol ·L−1.
7.5 Singlet oxygen measurements
7.5.1 ITQ (UPV-CSIC) system,used in chapter 3
The singlet oxygen phosphorescence decay traces after the laser pulse were reg-
istered at 1270 nm employing a Peltier-cooled (-62.8◦C) Hamamatsu NIR detector
operating at 588 V, coupled to a computer-controlled grating monochromator. A
pulsed Nd:YAG L52137 V LOTIS TII was used at the excitation wavelength of 266
nm. The single pulses were ca. 10 ns duration, and the energy was lower than 10
mJ/pulse.
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7.5.2 ISOF-CNR system, used in chapter 6
The pulse of a Nd:YAG laser, operating at 355 nm or 266 nm (20 ns fwhm),
was used for excitation of the samples dissolved in air-equilibrated acetonitrile.
A preamplified (low impedance) Ge-photodiode (Applied Detector Corp., Model
403HS, time resolution 300 ns), cooled at 77 K and equipped with a 5 mm thick AR
coated silicon metal filter with wavelength pass >1.1 µm and an interference filter
at 1.27 µm, was used to measure emission of singlet oxygen at 1270 nm in right
angle geometry. The photodiode output current was fed into a digital oscilloscope.
7.6 NMR and HRMS spectroscopic characteriza-
tion
1H NMR and 13C NMR were recorded on a 300 MHz spectrometer (U300,
Varian) operating in the Fourier transform mode. The chemical shifts are reported
in ppm (parts per million), using TMS as the internal reference. HRMS was per-
formed on a Waters ACQUITY XevoQToF spectrometer (Waters Corp.) connected
to the UPLC system via an electrospray ionization (ESI) interface. The ESI source
was operated in positive ionization mode using leucine-enkephalin as the lock mass
([M+H]+ ion m/z 556.2771).
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Chapter 8
Summaries
8.1 Summary
Photosensitizing effects of xenobiotics are of increasing concern in public health
since modern lifestyle often associates sunlight exposure with the presence of chem-
ical substances in the skin. An important number of chemicals like perfumes, sun-
screen components, or therapeutic agents have been reported as photosensitizers.
In this context, a considerable effort has been made to design a model system for
photosafety assessment. Indeed, screening for phototoxicity is necessary at the
early phase of drug discovery process, even before introducing drugs and chemicals
into clinical therapy, to prevent undesired photoreactions in humans. In the case
of new pharmaceuticals, their phototoxic potential has to be tested when they ab-
sorb in the regions corresponding to the solar spectrum, that is, for wavelengths
>290 nm. So, there is an obvious need for a screening strategy based on in vitro
experiments. The goal of the present thesis was the photochemical study of differ-
ent photoactive drugs to investigate the key molecular aspects responsible for their
photosensitivity side effects.
In a first stage, rosuvastatin was considered in chapter 3 as representative
compound of the statin family. This lipid-lowering drug, also known as “super-
statin”, contains a 2-vinylbiphenyl-like moiety and has been previously described
to decompose under solar irradiation, yielding stable dihydrophenanthrene ana-
logues. During photophysical characterization of rosuvastatin, only a long-lived
transient at ca. 550 nm was observed and assigned to the primary photocycliza-
tion intermediate. Thus, the absence of detectable triplet-triplet absorption and
the low yield of fluorescence ruled out the role of the parent drug as an efficient
sensitizer. In this context, the attention was placed on the rosuvastatin main pho-
toproduct (ppRSV). Indeed, the photobehavior of this dihydrophenanthrene-like
compound presented the essential components needed for an efficient biomolecule
photosensitizer i.e. (i) a high intersystem crossing quantum yield (ΦISC =0.8), (ii)
a triplet excited state energy of ca. 67 kcal mol−1, and (iii) a quantum yield of
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singlet oxygen formation (Φ∆) of 0.3. Furthermore, laser flash photolysis studies
revealed a triplet-triplet energy transfer from the triplet excited state of ppRSV
to thymidine, leading to the formation of cyclobutane thymidine dimers, an impor-
tant type of DNA lesion. Finally, tryptophan was used as a probe to investigate the
Type I and/or Type II character of ppRSV-mediated oxidation. In this way, both
an electron transfer process giving rise to the tryptophanyl radical and a singlet
oxygen mediated oxidation were observed. On the basis of the obtained results,
rosuvastatin, through its major photoproduct ppRSV, should be considered as a
potential sensitizer.
Then, itraconazole (ITZ), a broad-spectrum antifungal agent, was chosen as
main character of chapter 4. Its photochemical properties were investigated in con-
nection with its reported skin photosensitivity disorders. Steady state photolysis,
fluorescence and phosphorescence experiments were performed to understand ITZ
photoreactivity in biological media. The drug is unstable under UVB irradiation,
suffering a primary dehalogenation of the 2,4-dichlorophenyl moiety that occurs
mainly at the ortho-position. In poorly H-donating solvents, as acetonitrile, the
major photoproduct arises from intramolecular attack of the initially generated
aryl radical to the triazole ring. In addition, reduced compounds resulting from
homolytic cleavage of the C-Cl bond in ortho or para positions and subsequent H-
abstraction from the medium are obtained to a lesser extent. In good H-donating
solvents, such as ethanol, the main photoproducts are formed by reductive dehalo-
genation. Furthermore, irradiation of a model dyad containing a tryptophan unit
and the reactive 2,4-dichlorophenyl moiety of itraconazole leads to formation of
a new covalent link between these two substructures revealing that homolysis of
the C-Cl bond of ITZ can result in alkylation of reactive amino acid residues of
proteins, leading to formation of covalent photoadducts. Therefore, it has been es-
tablished that the key process in the photosensitization by itraconazole is cleavage
of the carbon-halogen bond, which leads to aryl radicals and chlorine atoms. These
highly reactive species might be responsible for extensive free radical-mediated bi-
ological damage, including lipid peroxidation or photobinding to proteins.
In chapter 5, photobehavior of imatinib (IMT) was addressed. This is a
promising tyrosine kinase inhibitor used in the treatment of some types of human
cancer, which constitutes a successful example of rational drug design based on the
optimization of the chemical structure to reach an improved pharmacological activ-
ity. Cutaneous reactions, such as increased photosensitivity or pseudoporphyria,
are among the most common nonhematological IMT side effects; however, the
molecular bases of these clinical observations have not been unveiled yet. Thus,
to gain insight into the IMT photosensitizing properties, its photobehavior was
studied together with that of its potentially photoactive anilino-pyrimidine and
pyridyl-pyrimidine fragments. In this context, steady-state and time resolved flu-
orescence, as well as laser flash photolysis experiments were run, and the DNA
photosensitization potential was investigated by means of single strand breaks
detection using agarose gel electrophoresis. The obtained results revealed that
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the drug itself and its anilino-pyrimidine fragment are not DNA-photosensitizers.
By contrast, the pyridyl-pyrimidine substructure displayed a marked photogeno-
toxic potential, which was associated with the generation of a long-lived triplet
excited state. Interestingly, this reactive species was efficiently quenched by ben-
zanilide, another molecular fragment of IMT. Clearly, integration of the photoac-
tive pyridyl-pyrimidine moiety in a more complex structure strongly modifies its
photobehavior, which in this case is fortunate as it leads to an improved toxi-
cological profile. Thus, on the bases of the experimental results, direct in vivo
photosensitization by IMT seems unlikely. Instead, the reported photosensitivity
disorders could be related to indirect processes, such as the previously suggested
impairment of melanogenesis or the accumulation of endogenous porphyrins.
Finally, a possible source of errors in the TEMPO/EPR method for singlet
oxygen detection was analyzed. For many biological and biomedical studies, it is es-
sential to detect the production of 1O2 and to quantify its production yield. Among
the available methods, detection of the characteristic 1270 nm phosphorescence of
singlet oxygen by time-resolved near infrared (TRNIR) emission constitutes the
most direct and unambiguous approach. An alternative indirect method is elec-
tron paramagnetic resonance (EPR) in combination with trapping. This is based on
the detection of the TEMPO free radical formed after oxidation of TEMP (2,2,6,6-
tetramethylpiperidine) by singlet oxygen. Although the TEMPO/EPR method has
been largely employed, it can produce misleading data. This was demonstrated by
the present study, where the quantum yields of singlet oxygen formation obtained
by TRNIR emission and by the TEMPO/EPR method were compared for a set of
well-known photosensitizers. The results revealed that the TEMPO/EPR method
leads to significant overestimation of singlet oxygen yield when the singlet or triplet
excited state of the photosensitizers were efficiently quenched by TEMP, acting as
electron donor. In such case, generation of the TEMP+• radical cation, followed by
deprotonation and reaction with molecular oxygen gives rise to a EPR detectable
TEMPO signal that is not associated with singlet oxygen production. This knowl-
edge is essential for an appropriate and error-free application of the TEMPO/EPR
method in chemical, biological and medical studies.
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8.2 Resumen
Los efectos fotosensibilizantes de los xenobióticos son de creciente interés para
la salud pública ya que el estilo de vida moderna a menudo asocia la exposición
solar con la presencia de sustancias químicas en la piel. Un número importante
de productos químicos como perfumes, protectores solares, o agentes terapéuticos
han sido reconocidos como fotosensibilizadores. En este contexto, se ha realizado
un considerable esfuerzo para diseñar un sistema modelo para evaluar la seguridad
frente la luz.De hecho, el control de la fototoxicidad es necesario en las primeras
fases del proceso de desarrollo de fármacos, incluso antes de la introducción de
medicamentos y productos químicos en la terapia clínica, para prevenir fotorreac-
ciones no deseadas en humanos. En el caso de nuevos productos farmacéuticos, su
potencial fototóxico tiene que ser probado cuando éstos absorben en las regiones
correspondientes del espectro solar, es decir, para longitudes de onda>290 nm.
Por lo tanto, existe la evidente necesidad de una estrategia de control basada en
experimentos in vitro.El objetivo de la presente tesis fue el estudio fotoquímico de
diferentes fármacos fotoactivos para investigar los mecanismos moleculares clave
responsables de sus efectos secundarios de fotosensibilidad.
En una primera etapa, en el capítulo 3 , la rosuvastatina fue elegida como
compuesto representativo de la familia de las estatinas. Este fármaco reductor de
lípidos, también conocido como ”superestatina”, contiene un grupo 2-vinilbifenilo
y, como se ha descrito previamente se descompone bajo irradiación solar, dando
análogos de dihidrofenantreno estables. Durante la caracterización fotofísica de la
rosuvastatina, se observó sólo una especie transitoria de larga duración a aproxi-
madamente 550 nm y fue asignada al intermedio primario de la fotociclación. Por
lo tanto, la ausencia de una absorción triplete-triplete y el bajo rendimiento de
fluorescencia descartan el papel del fármaco original como sensibilizador eficiente.
En este contexto, se centró la atención en el fotoproducto principal de la rosuvas-
tatina (ppRSV). De hecho, las propiedades de este compuesto dihidrofenantreno
presentaron los rasgos esenciales necesarios para ser un fotosensibilizador eficiente,
es decir, (i) un alto rendimiento cuántico de cruce intersistemas (ΦISC = 0.8), (ii)
una energía de estado excitado triplete de aproximadamente 67 kcal mol−1, y (iii)
un rendimiento cuántico de formación de oxígeno singlete (Φ∆) de 0.3. Además,
los estudios de fotólisis de destello láser revelaron una transferencia de energía
triplete-triplete desde el estado excitado triplete de ppRSV a la timidina, lo que
lleva a la formación de dímeros ciclobutánicos de timidina, un tipo importante de
lesión del ADN. Por último, el triptófano se utilizó como sonda para investigar la
oxidación de Tipo I o de Tipo II mediada por ppRSV. De esta manera, se observó
un proceso de transferencia de electrones que da lugar al radical triptofanilo y una
oxidación mediada por oxígeno singlete. Sobre la base de los resultados obtenidos,
la rosuvastatina, a través de su fotoproducto mayoritario ppRSV, debe ser con-
siderada como un potencial sensibilizador.
Posteriormente, el itraconazol (ITZ), un agente antifúngico de amplio espec-
tro, fue elegido como protagonista principal del capítulo 4. Sus propiedades foto-
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químicas fueron investigadas en relación con los efectos adversos como la fotosen-
sibilidad. Se realizaron estudios de fotólisis en estado estacionario, experimentos
de fluorescencia y fosforescencia para comprender la fotorreactividad del ITZ en
medios biológicos. El fármaco es inestable bajo irradiación UVB, dando lugar a
una deshalogenación en la parte de 2,4-diclorofenilo principalmente en la posición
orto. En disolventes como el acetonitrilo, el principal fotoproducto surge del ataque
intramolecular del radical arilo, generado inicialmente, al anillo de triazol. Además,
los compuestos resultantes de la ruptura homolítica del enlace C-Cl en posiciones
orto o para y posterior abstracción de hidrógeno desde el medio se obtienen en
menor cantidad. En disolventes capaces de ceder H más facilmente, tales como
el etanol, los principales fotoproductos se forman por deshalogenación reductiva.
Además, la irradiación de una diada modelo, que contiene una unidad de triptó-
fano y el radical reactivo , 2,4-diclorofenilo del itraconazol, se obtiene la formación
de un nuevo enlace covalente entre estas dos subestructuras. Esto revela que la
homólisis del enlace C-Cl del ITZ puede resultar en la alquilación de residuos de
aminoácidos reactivos de las proteínas, que posteriormente conducirá a la forma-
ción de fotoaductos covalentes. Por lo tanto, se ha establecido que el proceso clave
en la fotosensibilización del itraconazol es la ruptura del enlace carbono-halógeno,
que produce radicales arilo y átomos de cloro. Estas especies altamente reactivas
pueden ser responsables de importantes daños biológicos mediados por radicales
libres, incluyendo la peroxidación lipídica o fotounión a las proteínas.
En el capítulo 5, se aborda el comportamiento fotoquímico del imatinib (IMT).
Este es un inhibidor de la tirosina quinasa utilizado en el tratamiento de algunos
tipos de cáncer humano. Este fármaco constituye un claro ejemplo de diseño
racional basado en la optimización de la estructura química para alcanzar una mejor
actividad farmacológica. Las reacciones cutáneas, como el aumento de fotosensibi-
lidad o pseudoporfiria, son algunos de los efectos secundarios no hematológicos más
comunes del IMT; sin embargo, las bases moleculares de estas indicaciones clínicas
no se conocen todavía. Por lo tanto, para comprender mejor las propiedades foto-
sensibilizantes del IMT, se estudió su comportamiento fotoquímico junto con el de
sus fragmentos potencialmente fotoactivos: anilino-pirimidina y piridilo-pirimidina.
En este contexto, se llevaron a cabo experimentos de fluorescencia en estado esta-
cionario y en tiempo resuelto, así como de fotólisis de destello láser, y se investigó el
potencial de fotosensibilización hacia el ADN por medio de la detección de roturas
de cadena utilizando la electroforesis en gel de agarosa. Los resultados obtenidos
revelaron que el fármaco en sí y su fragmento anilino-pirimidina no son fotosensibi-
lizadores de ADN. Por el contrario, la subestructura piridilo-pirimidina exhibe un
marcado potencial fotogenotóxico, que se asoció con la presencia de un estado exci-
tado triplete de larga duración. Curiosamente, esta especie reactiva se desactiva de
manera eficiente por benzanilida, otro fragmento molecular del IMT. Claramente,
la integración de la fracción fotoactiva piridilo-pirimidina en una estructura más
compleja modifica fuertemente su comportamiento fotoquímico, que en este caso
resulta afortunado, lo que conduce a un perfil toxicológico mejorado. Por lo tanto,
sobre la base de los resultados experimentales, una fotosensibilización directa in
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vivo por el IMT parece poco probable. En cambio, los trastornos de fotosensibili-
dad reportados podrían estar relacionados con los procesos indirectos, tales como
la reducción de la melanogénesis, sugerida anteriormente, o la acumulación de por-
firinas endógenas.
Por último, se analizó la restricción del método TEMPO / EPR para la de-
tección del oxígeno de singlete. Para muchos estudios biológicos y biomédicos,
es esencial detectar la producción de 1O2 y cuantificar su rendimiento cuántico.
Entre los métodos disponibles, la detección de la fosforescencia característica del
oxígeno singlete a 1270 nm por emisión resuelta en el tiempo en el rango del infrar-
rojo cercano (TRNIR), constituye el enfoque más directo y sin ambigüedades. Un
método indirecto alternativo es la resonancia paramagnética electrónica (EPR) en
combinación con una sonda. Esto se basa en la detección del radical libre TEMPO
formado después de la oxidación del TEMP (2,2,6,6-tetrametilpiperidina) por el
oxígeno singlete. Aunque el método TEMPO / EPR se ha utilizado frecuente-
mente, puede dar lugar a artefactos. Esto fue demostrado en el presente estudio,
donde se compararon los rendimientos cuánticos de formación de oxígeno singlete
obtenidos por emisión TRNIR y por el método TEMPO/EPR para un conjunto de
fotosensibilizadores. Los resultados revelaron que el método TEMPO/EPR con-
duce a una sobrestimación significativa del rendimiento de oxígeno singlete cuando
el estado excitado singlete o triplete de los fotosensibilizadores es desactivado de
manera eficiente por TEMP, que actúa como donador de electrones. En tal caso,
la generación de catión radical TEMP+•, seguida por desprotonación y reacción
con oxígeno molecular, da lugar a una señal detectable por EPR que no está asoci-
ada con la producción de oxígeno singlete. Este conocimiento es esencial para una
aplicación adecuada y sin errores del método EPR/TEMPO en química, biológica
y medicina.
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8.3 Resum
Els efectes fotosensibilitzants dels xenobiòtics són de creixent interès per a
la salut pública ja que l’estil de vida moderna sovint s’associa l’exposició solar
amb la presència de substàncies químiques sobre la pell. Un nombre important
de productes químics com perfums, protectors solars, o agents terapèutics han
sigut reconeguts com fotosensibilitzadors. En aquest context, s’han fet una sèrie
d’esforços per a dissenyar un sistema model per a avaluar la seguretat front la llum.
De fet, el control de la fototoxicitat és necessari en les primeres fases del procés de
desenvolupament de fàrmacs, fins i tot abans de la introducció de medicaments i
productes químics en la teràpia clínica, per a prevenir fotoreaccions no desitjades
en humans. En el cas de nous productes farmacèutics, el seu potencial fototòxic ha
de ser provat quan aquests absorbeixen en les regions corresponents de l’espectre
solar, és a dir, per a longituds d’ona> 290 nm. Per tant, existeix l’evident neces-
sitat d’una estratègia de control basada en experiments in vitro.L’objectiu de la
present tesi va ser l’estudi fotoquímic de diferents fàrmacs fotoactius per a inves-
tigar els mecanismes moleculars clau responsables dels seus efectes secundaris de
fotosensibilitat.
En una primera etapa, en el capítol 3, la rosuvastatina va ser triada com a
compost representatiu de la família de les estatines. Aquest fàrmac reductor de
lípids, també conegut com "superestatina", conté una resta 2-vinilbifenilo i, com
s’ha descrit prèviament es descompon sota irradiació solar, donant anàlegs de di-
hidrofenantrè estables. Durant la caracterització fotofísica de la rosuvastatina, es
va observar només una espècie transitòria de llarga durada a aproximadament 550
nm i es va assignar a l’intermedi primari de la fotociclació. Per tant, l’absència
d’una absorció triplet-triplet i el baix rendiment de fluorescència descarten el pa-
per del fàrmac original com sensibilizator eficient. En aquest context, es va enfocar
l’atenció en el fotoproducte principal de la rosuvastatina (ppRSV). De fet, les
propietats d’aquest compost dihidrofenantré van presentar els components essen-
cials necessaris per a ser un fotosensibilizator eficient, és a dir, (i) un alt rendiment
quàntic de creuament intersistems (ΦISC = 0.8), (ii) una energia d’estat excitat
triplet d’aprox 67 mol−1 kcal, i (iii) un rendiment quàntic de formació d’oxigen
molecular de singlet (Φ∆) de 0.3. A més, els estudis de fotòlisi de flaix làser van
revelar una transferència d’energia triplet-triplet des de l’estat excitat triplet de
ppRSV al de la timidina, la qual cosa porta a la formació de dímers ciclobutànics
de timidina, un tipus important de lesió de l’ADN. Finalment, el triptòfan es va
utilitzar com sonda per a investigar l’oxidació de tipus I o de tipus II intervin-
guda per ppRSV. D’aquesta manera, es va observar un procés de transferència
d’electrons que dóna lloc al radical triptofanil i una oxidació intervinguda per oxi-
gen singlet. Sobre la base dels resultats obtinguts, la rosuvastatina, a través del seu
major fotoproducteppRSV, ha de ser considerada com un potencial sensibilitzator.
Posteriorment, l’itraconazol (ITZ), un agent antifúngi d’ampli espectre, va ser
triat com a protagonista principal del capítol 4. Les seues propietats fotoquímiques
van ser investigades a causa de les molèsties relacionades amb la fotosensibilitat.
81
CHAPTER 8. SUMMARIES
Fotòlisi en estat estacionari, experiments de fluorescència i fosforescència es van rea-
litzar per a comprendre la fotoreactivitat del ITZ en mitjans biològics. El fàrmac
és inestable sota irradiació UVB, donant lloc a una dehsalogenació primària en la
fracció 2,4-diclorofenil principalment en la posició orto. En acetonitril, el principal
fotoproducte sorgeix de l’atac intramolecular del radical arilo, generat inicialment,
a l’anell de triazol. A més, els compostos resultants de la ruptura homolítica de
l’enllaç C-Cl en posicions orto o para i posterior abstracció d’hidrogen des del mitjà
s’obtenen en menor quantitat. En dissolvents que cedeixen fàcilment H, tals com
l’etanol, els principals fotoproducte es formen per deshalogenació reductiva. A
més, la irradiació d’una diada model, que conté una unitat de triptòfan i el radical
2,4-diclorofenil reactiu del itraconazol, es conclou amb la formació d’un nou enllaç
covalent entre aquestes dues subestructures. Açò revela que l’ homólisi de l’enllaç
C-Cl de ITZ pot acabar amb l’alquilació de residus d’aminoàcids reactius de les
proteïnes, que posteriorment condueixen a la formació de fotoaductes covalents.
Per tant, s’ha establit que el procés clau en la fotosensibilització de l’itraconazol
és la ruptura de l’enllac carboni-halogen, que produeix radicals arilo i àtoms de
clor. Aquestes espècies altament reactives poden ser responsables d’importants
danys biològics intervinguts per radicals lliures, incloent la peroxidació lipídica o
fotounió a les proteïnes.
En el capítol 5, es parla del comportament fotoquímic de l’imatinib (IMT).
Este és un inhibidor de la tirosina quinasa utilitzat en el tractament d’alguns tipus
de càncer humà. Aquest fàrmac constitueix un clar exemple de disseny racional de
fàrmacs basat en l’optimització de l’estructura química per a aconseguir una millor
activitat farmacològica. Les reaccions cutànies, com l’augment de fotosensibilitat o
pseudoporfíria, són alguns dels efectes secundaris no hematològics més comuns de
l’IMT; no obstant açò, les bases moleculars d’aquestes indicacions clíniques no es
coneixen encara. Per tant, per a comprendre millor les propietats fotosensibilitzants
de l’IMT, es va estudiar el seu comportament fotoquímic juntament amb els de els
seus fragments potencialment fotoactius: anilino-pirimidina i piridilo-pirimidina.
En aquest context, es van dur a terme experiments de fluorescència en estat esta-
cionari i en temps resolt, així com de fotòlisi de flaix làser, i es va investigar el
potencial de fotosensibilització cap a l’ADN per mitjà de la detecció de trenca-
ments de cadena utilitzant l’electroforesi en gel de agarosa. Els resultats obtinguts
van revelar que el fàrmac en sí i el seu fragment anilino-pirimidina no són fotosen-
sibilitzadors d’ADN. En cas contrari, la subestructura piridilo-pirimidina presenta
un marcat potencial fotogenotòxic, que es va associar amb la presència d’un estat
excitat triplet de llarga durada. Curiosament, aquesta espècie reactiva es desactiva
de manera eficient per benzanilida, un altre fragment molecular de l’IMT. Clara-
ment, la integració de la fracció fotoactiva piridilo-pirimidina en una estructura
més complexa modifica fortament el seu comportament fotoquímic, que en aquest
cas resulta afortunata, ja que condueix a un perfil toxicològic millorat. Per tant,
sobre la base dels resultats experimentals, per l’IMT sembla poc probable una
fotosensibilització directa in vivo. En canvi, els trastorns de fotosensibilitat re-
portats podrien estar relacionats amb els processos indirectes, tals com la reducció
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de la melanogènesi, suggerida anteriorment, o l’acumulació de porfirines endògenes.
Finalment, es va analitzar una errada present en el mètode TEMPO / EPR per
a la detecció d’oxigen de singlet. Per a molts estudis biològics i biomèdics, és essen-
cial detectar la producció de 1O2 i quantificar el seu rendiment quàntic. Entre els
mètodes disponibles, la detecció de la fosforescència característica d’oxigen singlet
a 1270 nm, emissió resolta en el temps en l’infraroig proper (TRNIR), constitueix
l’enfocament més directe i sense ambigüitats. Un mètode indirecte alternatiu és la
ressonància paramagnètica electrònica (EPR) en combinació amb “trapping”. Açò
es basa en la detecció del radical lliure TEMPO format després de l’oxidació del
TEMP (2,2,6,6-tetrametilpiperidina) per l’oxigen singlet. Encara que el mètode
TEMPO / EPR s’ha utilitzat freqüentment, pot produir resultats ambigus. Açò
va ser demostrat pel present estudi, on es van comparar els rendiments quàntics de
formació d’oxigen singlet obtinguts per emissió TRNIR i pel mètode TEMPO/EPR
per a un conjunt de fotosensibilizadors acreditats. Els resultats van revelar que el
mètode TEMPO/EPR condueix a una sobrestimació significativa del rendiment
d’oxigen singlet quan l’estat excitat singlet o triplet dels fotosensibilitzadors és de-
sactivat de manera eficient per TEMP, que actua com a donador d’electrons. En
tal cas, la generació de catió radical TEMP+•, seguit per desprotonació i reacció
amb oxigen molecular, dóna lloc a una senyal detectable per EPR que no està
associada amb la producció d’oxigen singlet. Aquest coneixement és essencial per
a una aplicació adequada i sense errors en el mètode EPR/TEMPO en química,
biologia i en estudis mèdics.
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Chapter 9
General conclusions
In the present thesis, the photosensitization capability of three drugs has been
evaluated. Photochemical, photophysical and photobiological studies have allowed
determining the main molecular mechanisms responsible for the sensitizing pro-
cesses.
One of the main conclusions is that instability of the drug under irradiation
does not avoid a possible phototoxicity. On the contrary, the results obtained for
rosuvastatin and itraconazole have shown that photodegradation of the drug could
provide photosensitization through two different paths:
• A rearrangement of chemical bonds could give rise to a photoproduct that
is the real responsible for the adverse effects ascribed to parent drug. This
has been established in the chapter 3 where ppRSV, the photoproduct of
rosuvastatin, is proposed to be the real sensitizer
• The photoreaction intermediates could be the reactive species. This possibil-
ity has been illustrated for itraconazole in chapter 4, In this case, the aryl
radical formed through UVB-mediated photodehalogenation could be the re-
sponsible for tryptophan alkylation. This has been studied by means of a
model dyad composed by the itraconazole aryl moiety and tryptophan.
An interesting case relies on the study of the tyrosine kinase inhibitor ima-
tinib in chapter 5, which reveals that photosensitizing potential is neither pre-
dictable by the absorption in the UV region nor by the phototoxic potential of its
substructures. Indeed, the two chromophores of the drug (ie. anilino-pyrimidine
and pyridyl-pyrimidine) exhibit triplet excited states, which could be in the origin
of biomolecule sensitization. In particular, the pyridyl-pyrimidine fragment has
been shown to photoinduce DNA single strand breaks, whereas imatinib does not.
This has been associated with the interference of a third moiety that promotes an
internal deactivation.
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Finally, the limitation of the TEMPO/EPR methodology has been established.
This technique is widely used in biochemical studies in order to determine the pro-
duction of singlet oxygen. It has been demonstrated in chapter 6 that particular
attention has to be held on 1O2 sensitizers able to oxidize the TEMP molecule by a
photoinduced electron transfer. In this case, formation of TEMPO does not result
from its reaction with 1O2 but from a reaction of molecular oxygen with TEMP
radical cation.
Taking these results altogether, the following flow diagram can be proposed in
order to evaluate the photosensitizing potential of chemicals:
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Appendix A
Appendix of chapter 4
A.1 Itraconazole
O
O
Cl Cl
N
NN
O N N N
N
N
O
1H-NMR (300 MHz, CDCl3)δ 8,22 (s, 1H), 7,91 (s ,1H) 7,64 (s,1H) 7,59 (d, J=
8,4 Hz, 1H), 7,50 (d, J= 2,1 Hz, 1H) 7,44 (d, J= 9,0 Hz, 2H), 7,27 (dd, J= 8,4 ; 2,1
Hz, 1H), 7,04 (d, J=9,0 Hz, 2H), 6,97 (d, J= 8,7 Hz, 2H), 6,82 (d, J= 8,7 Hz, 2H)
4,85 (d, J= 14,7 1H), 4,76 (d, J= 14,7 1H), 4,38 (m,1H) 4,31 (m, 1H), 3,93 (dd, J=
8,4 ; 6,7 Hz, 1H), 3,84 (m, 1H), 3,80 (m, 1H) 3,51 (dd, J= 9,7 ; 6,3 Hz, 1H) 3,40
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(m, 2H), 3,27 (m, 2H), 1,89 (m ,1H), 1,73 (m, 1H) 1,40 (d, J=6,7 Hz, 1H), 0,92 (t,
J= 7,4 Hz, 1H). 13C-NMR (75 MHz, CDCl3)δ 152,0(C) 151,4 (C+CH), 150,5 (C)
144,9 (C+CH) 136,1 (C) 134,1 (C) 133,9 (CH) 133,1(CH) 131,5 (CH) 129,6 (CH)
127,3 (CH), 126,0 (C), 123,6 (2XCH) 118,6 (2XCH) 116,7 (2XCH), 115,3 (2XCH)
107,7(C) 74,7 (CH) 67,7 (CH2) 67,5 (CH2) 53,6 (CH2) 52,7 (CH) 50,7 (2XCH2)
49,2 (2XCH2) 28,5 (CH2) 19,3 (CH3) 10,8 (CH3).
90
A.2. PHOTOPRODUCT 2
A.2 Photoproduct 2
O
O
Cl
N
N
N
O N N N
N
N
O
1H-NMR (300 MHz, CDCl3)δ 8.09 (d,1H) 8.00 (d, 1H), 7.62 (s, 1H), 7.59 (d,
J = 8.3 Hz, 1H), 7.49 (dd, J = 8.3 Hz, J’= 2.1 Hz, 1H), 7.43 (d, J = 9.0 Hz, 2H),
7.03 (d, J = 9.0 Hz, 2H), 6.94 (AA’BB’, 4H), 4.76 (m, 1H), 4.61 (d, J = 13.7 Hz,
1H), 4.51 (d, J = 13.7 Hz, 1H), 4.37 (dd, J = 7.0 Hz, J’= 6.5 Hz, 1H), 4.29 (m,
1H), 4.22 (dd, J = 7.0 Hz, J’ = 6.5 Hz, 1H), 4.15 (m, 2H), 3.37 (m, 4H), 3.25 (m,
4H), 1.87 (m, 1H), 1.72 (m, 1H), 1.39 (d, J = 6.7 Hz,3H), 0.91 (t, J = 7.4 Hz,
3H). 13C-NMR (75 MHz, CDCl3)δ 152.7 (C), 152.0 (C), 151.9 (CH), 150.5 (C),
148.9 (C), 146.3 (C), 136.6 (C), 133.9 (C), 132.9 (CH), 130.6 (CH), 126.1 (CH),
126.0 (C), 125.4 (C), 125.0 (CH), 123.6 (CH), 118.5 (CH), 116.7 (CH), 115.5 (CH),
105.4 (C), 76.4 (CH), 67.7 (CH2), 67.0 (CH2), 54.0 (CH2), 52.7 (CH), 50.6 (CH2),
49.3 (CH2), 29.7 (CH2), 19.3 (CH3), 10.8 (CH3). HRMS (ESI+) Calculated for
C35H38ClN8O4 (M+H)+:
669.2698, Found: 669.2704.
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A.3 Photoproduct 3
O
O
Cl
N
NN
O N N N
N
N
O
1H-NMR (300 MHz, CDCl3)δ 8.19 (s ,1H), 7.91 (s ,1H), 7.62 (s ,1H), 7.47 (d,
J = 9.1 Hz, 2H), 7.43 (d, J = 9.1 Hz, 2H), 7.37 (d, J = 9.1 Hz, 2H), 7.02 (d, J= 9.1
Hz, 2H), 6.93 (d, J = 9.1 Hz, 2H), 6.80 (d, J =9.1 Hz, 2H), 4.50 (s, 2H), 4.40-4.25
(m, 2H), 3.89 (dd, J = 5.4 Hz, J’= 4.3 Hz, 1H), 3.81 (dd, J = 5.4 Hz, J’= 3.1 Hz,
1H), 3.76 (dd, J = 6.2 Hz, J’= 3.1 Hz, 1H), 3.47 (dd, J = 6.2 Hz, J’= 4.3 Hz, 1H),
3.35 (m, 4H), 3.23 (m, 4H), 1.87 (m ,1H), 1.71 (m, 1H), 1.39 (d, J = 6.7 Hz, 3H),
0.90 (t, J = 7.9 Hz, 3H).
13C-NMR (75 MHz, CDCl3)δ 152.7 (C), 152.1 (C), 151.3 (C), 150.6 (CH),
146.0 (C), 144.8 (CH), 137.4 (C), 135.4 (C), 133.9 (CH), 128.9 (CH), 127.3 (CH),
125.9 (C), 123.6 (CH), 118.5 (CH), 116.7 (CH), 115.3 (CH), 107.8 (C), 74.7 (CH),
67.9 (CH2), 67.4 (CH2), 55.8 (CH2), 52.7 (CH), 50.6 (CH2), 49.3 (CH2), 28.4
(CH2), 19.3 (CH3), 10.8 (CH3).
HRMS (ESI+) Calculated for C35H40ClN8O4 (M+H)+:
671.2861, Found: 671.2856
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A.4 Photoproduct 4
1H-NMR (300 MHz, CDCl3)δ 8.24 (br s, 1H), 7.92 (br s, 1H) ,7.66 (dd, J =
7.4 Hz, J’= 1.9 Hz, 1H), 7.62 (br s, 1H), 7.47 (m, 1H), 7.43 (d, J = 9.1 Hz, 2H),
7.36-7.22 (m, 2H), 7.04 (d, J = 9.1 Hz, 2H), 6.98 (d, J =9.0 Hz, 2H), 6.81 (d, J
=9.0 Hz, 2H), 4.90 (d, J =14.7 Hz, 1H), 4.79 (d, J = 14.7 Hz, 1H), 4.38 (m, 1H),
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O
O
Cl
N
NN
O N N N
N
N
O
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4.29 (m, 1H), 3.93 (dd, J = 8.4 Hz, J’= 6.8 Hz, 1H), 3.83-3.77 (m, 2H), 3.47 (dd,
J = 9.6 Hz, J’= 6.4 Hz, 1H), 3.39 (m, 4H), 3.27 (m, 4H), 1.97-1.67 (m, 2H), 1.39
(d, J = 7.0 Hz, 3H), 0.91 (t, J = 7.4 Hz, 3H).
13C-NMR (75 MHz, CDCl3)δ 153.0 (C), 152.5 (C), 152.0 (C), 150.4 (CH),
135.3 (CH), 133.9 (CH), 132.3 (C), 131.7 (CH), 130.8 (CH), 128.6 (CH), 127.0
(CH), 126.1 (C), 123.6 (CH), 118.8 (CH), 116.8 (CH), 115.4 (CH), 107.9 (C), 74.5
(CH), 67.8 (CH2), 67.4 (CH2), 53.7 (CH2), 52.7 (CH), 50.9 (CH2), 49.1 (CH2),
28.4 (CH2), 19.3 (CH3), 10.8 (CH3).
HRMS (ESI+) Calculated for C35H40ClN8O4 (M+H)+:
671.2861, Found: 671.2861.
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A.5 Model dyad 5
Cl
Cl O
N
H NH
OO
1H-NMR (300 MHz, CD3CN)δ 9.19 (br s, 1H) 7.52 (d, J = 7.9 Hz, 1H), 7.45-
7.40 (m, 2H), 7.26-7.05 (m, 5H), 6.69 (br s, 1H) 4.73 (m, 1H) 3.66 (s, 3H), 3.60
(s, 2H), 3.27 (dd, J = 14.7 Hz, J’= 5.4 Hz, 1H), 3.18 (dd, J = 14.7 Hz, J’= 7.2
Hz,1H).
13C-NMR (75 MHz, CD3CN)δ 171.8 (C), 168.5 (C), 136.1 (C), 134.6 (C), 132.7
(C), 132.4 (CH), 132.4 (C), 128.5 (CH), 127.1 (C), 126.9 (CH), 123.4 (CH), 121.3
(CH), 118.7 (CH), 117.9 (CH), 111.1 (CH), 109.2 (C), 52.9 (CH), 51.4 (CH3), 39.1
(CH2), 26.8 (CH2).
HRMS (ESI+) Calculated for C20H19Cl2N2O3 (M+H)+: 405.0773, Found:
405.0780.
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A.6 Model dyad 6
1H-NMR (300 MHz, CD3CN)δ 9.25 (br s, 1H), 7.67-7.09 (m,7H), 5.34 (d, J =
12 Hz, 1H), 4.56 (dt, J = 12 Hz, J’= 3 Hz, 1H), 3.73 (d, J = 18 Hz, 1H), 3.70 (s,
3H), 3.45 (dd, J = 15 Hz, J’ = 3 Hz, 1H), 3.41 (d, J = 18 Hz, 1H), 2.45 (dd, J =
15 Hz, J’= 12 Hz, 1H).
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NH
HN
O
O
O
Cl
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13C-NMR (75 MHz, CD3CN)δ 172.9 (C), 171.2 (C), 137.2 (C), 135.5 (C), 133.5
(C), 131.9 (CH), 131.8 (C), 131.4 (CH), 129.1 (CH), 127.1 (C), 122.1 (CH), 119.1
(CH), 117.6 (CH), 110.8 (CH), 110.8 (C), 110.1 (C), 57.6 (CH), 51.4 (CH3), 42.1
(CH2), 28.5 (CH2).
HRMS (ESI+) Calculated for C20H18ClN2O3 (M+H)+:
369.1006, Found: 369.1002.
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Appendix B
Appendix of chapter 5
B.1 2-phenylaminopyrimidine (1)
N
N
H
N
Aminopyrimidine (0.210 g, 2.2 mmol), CuI (0.095 g, 0.5 mmol) and anhydrous
K2CO3 (0.552 g, 4 mmol) were added to two neck flask fitted with magnetic stirbar
and septum. The flask was evacuated and back filled with N2 three times. Dioxane
(10 mL), bromobenzene (0.314 g, 2.0 mmol, 0.21 mL) and DMEDA (0.044 g, 0.5
mmol, 0.053 mL) were added with syringe at room temperature. The reaction mix-
ture was stirred at reflux for 22 h, and cooled to room temperature. Concentrated
ammonia (4 mL) and brine (20 mL) were added, and the mixture was extracted
with ethyl acetate (3×15 mL). The organic layers were concentrated in vacuo, and
the crude product was purified by column chromatography on silica gel (ethyl ac-
etate: dichloromethane 1:20 v/v, Rf: 0.25), and crystallized from n-hexane, to
provide 0.168 g (49% yield) product.
1H-NMR (300 MHz, CDCl3)δ 8.37 (d, J = 4.8, 2H ), 7.00-7.69 (m, 6H), 6.67
(t, J = 4.8, 1H); 13C-NMR (75 MHz, CDCl3)δ 159.9, 157.9, 139.2, 128.9, 122.9,
119.6, 112.5. HRMS (ESI+) Calculated for C10H10N3 (M+H)+: 172.0875; found
172.0870.
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B.2 4-(Pyridin-2-yl)-2-aminopyrimidine (2)
3-(dimethylamino)-1-(pyridin-2-yl) prop-2-en-1-one (0.4 g, 2.3 mmol) and guani-
dinium hydrochloride (0.23 g, 2.4 mmol, 1.05 eq.) were mixed in 5 mL of 2-
propanol. To the suspension was added 0.11 g of NaOH (2.7 mmol, 1.2 eq.) and
the mixture was refluxed for 18 h. The reaction was then cooled to 0◦C and the
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B.2. 4-(PYRIDIN-2-YL)-2-AMINOPYRIMIDINE (2)
N
N NH2
N
precipitate was filtered off, suspended in water, filtered off once more and washed
with 2-propanol and diethyl ether. The residue was dried in a vacuum desiccator
and the desired product was obtained as a white powder (0.24 g, yield = 61%).
TLC (ethyl acetate /acetonitrile 2/1 v/v) Rf: 0.40. 1H-NMR (300 MHz,
DMSO-d6)δ9.23 (dd, J = 2.3, 0.9 Hz, 1H), 8.68 (dd, J = 4.8, 1.7 Hz, 1H), 8.39
(ddd, J = 8.1, 2.4, 1.7 Hz, 1H), 8.36 (d, J = 5.1 Hz,1H), 7.53 (ddd, J = 8.0, 4.8,
0.9 Hz, 1H), 7.21 (d, J = 5.1 Hz, 1H), 6.78 (bb, 2H); ; 13C-NMR (75 MHz, DMSO-
d6)δ 163.8, 161.5, 159.3, 151.1, 147.9, 134.1, 132.4, 123.7, 106.0, HRMS (ESI+)
Calculated for C9H9N4 (M+H)+: 173.0827; found 173.0827.
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B.3 N-(3-aminophenyl)benzamide (3)
H2N
H
N
O
A solution of benzoyl chloride (0.24 g, 1.7 mmol, 0.2 mL) and activated zinc
(0.11 g, 1.7 mmol ) in 5 mL of anhydrous toluene was added dropwise to a mag-
netically stirred solution of the benzene-1,3-diamine (0.11 g, 3.6 mmol) in 5 mL
anhydrous toluene. The mixture stirred at room temperature for 18h, the progress
of the reaction was monitored by TLC. After completion of the reaction, it was
filtered and the solid cake washed with ether (50 mL). The combined filtrate was
extracted with saturated bicarbonate solution and dried over MgSO4. The organic
layers were concentrated in vacuo, and the crude product was purified by column
chromatography on silica gel (ethyl acetate: n-hexane 1:1 v/v, Rf: 0.35) and crys-
tallized from toluene/n-hexane at 4◦C, to provide 0.240 g (67% yield) of product
3.
1H-NMR (300 MHz, CDCl3)δ 7.90-7.80 (m, 2H), 7.77 (bb, 1H), 7.59-7.40 (m,
3H), 7.31 (t, J = 2.2 Hz, 1H), 7.12 (t, J = 8.0 Hz, 1H), 6.79 (ddd, J = 8.0, 2.0, 0.9
Hz, 1H), 6.47 (ddd, J = 8.0, 2.3, 0.9 Hz, 1H), 3,74 (bb, 2H). ; 13C-NMR (75 MHz,
CDCl3)δ 165.7, 147.3, 138.9, 135.2, 131.8, 129.8, 128.8, 126.9, 111.3,110.0, 106.8.
HRMS (ESI+) Calculated for C13H13N2O (M+H)+: 213.1028; found 213.1027.
104
B.3. N-(3-AMINOPHENYL)BENZAMIDE (3)
105
APPENDIX B. APPENDIX CHAPTER 5
106
Appendix C
Appendix of chapter 6
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Figure C.1: Normalized T-T absorption decay (λex = 355 nm, monitored at 480 nm) of argon-
bubbled ACN solution of PN (2.1×10−5 M) with increasing amount of TEMP: 0 (black), 10 (red),
50 (blue) mM. Inset: plot of the triplet decay rate constant vs. concentration of quencher.
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Figure C.2: Normalized T-T absorption decay (λex = 355 nm, monitored at 530 nm) of argon-
bubbled ACN solution of BP (3.1×10−3 M) with increasing amount of TEMP 0 (black), 0.2 (red),
0.6 (blue), 1 (purple) mM. Inset: plot of triplet decay rate constant vs. concentration of quencher
Figure C.3: T-T absorption decay (λex = 266 nm, monitored at 415 nm) of argon-bubbled ACN
solution of NP (7.1×10−3 M) with increasing amount of TEMP: 0 (black), 10 (red), 50 (blue)
mM.
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Figure C.4: Stern-Volmer plots of CBZ (3.5×10−5 M) in the presence of TEMP obtained from
steady-state (top) and time-resolved fluorescence (bottom) experiments.
Figure C.5: Stern-Volmer plots of NP (2.3×10−6 M) in the presence of TEMP obtained from
steady-state (top) and time-resolved fluorescence (bottom) experiments.
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Figure C.6: UV absorption spectra of an acetonitrile solution of BAHA (100 µM) in the absence
(black) and in the presence (red) of a stoichiometric amount of TEMP.
Figure C.7: TEMPO/EPR signals obtained for ACN solution of TEMP (50 mM) without (dotted
line) and in the presence of 5 mM BAHA under aerobic (red line) or anaerobic conditions (black
line).
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Publications
This thesis gave rise to the following publications:
1. Potential phototoxicity of rosuvastatin mediated by its dihydrophenanthrene-
like photoproduct; Giacomo Nardi; Virginie Lhiaubet-Vallet; Paula Leandro-
Garcia; Miguel A. Miranda Chem. Res. Toxicol., 2011, 24, 1779-1785
2. Generation of reactive aryl radical intermediates in the reductive photode-
halogenation of itraconazole ; Giacomo Nardi; M. Luisa Marin; Pierre A. de
Souza; Virginie Lhiaubet-Vallet; Miguel A. Miranda; RSC Adv., 2014, 4,
2687-2693
3. Photosensitization by imatinib. A photochemical and photobiological study
on the drug and its substructures, Giacomo Nardi; Virginie Lhiaubet-Vallet;
Miguel A. Miranda,Chem.Res.Toxicol., 2014, 27, 1990-1995
4. Scope and limitations of the TEMPO/EPR method for singlet oxygen de-
tection: the misleading role of electron transfer, Giacomo Nardi; Ilse Manet;
Sandra Monti; Miguel A. Miranda; Virginie Lhiaubet-Vallet, Free Radic.
Biol. Med., 2014, 77, 64-70
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